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ABSTRACT 
Astrocytes and microglia (glial cells) are active elements of the brain maintaining 
numerous homeostatic functions. Disturbances result in worsening of neuro-inflammation, 
traumatic brain injury, and various stages of brain tumors. Glial cells contribute to 
homeostasis for dynamic second messengers in the CNS, including intracellular calcium 
concentration ([Ca2+] i). Calcium is a central secondary messenger which signals for 
example, through the N-methyl-D-aspartate (NMDA) glutamate receptor on the neuronal 
membrane. A large, dynamic Ca2+ influx ensues after glutamate binds to the NMDA 
receptor. This influx initiates several molecular mechanisms within the cell. Disturbances 
in calcium homeostasis can lead to neurological diseases such as epilepsy and major 
depressive disorder.   
In this project, we set out to gain a better understanding of the effect of glial density 
on neural signalling. This was done by accomplishing four main objectives: 
1.  Develop neural micro-environments with quantifiable variations in glial cell 
densities. 
2.  Use calcium imaging methods to analyze the calcium information processing 
capacity of the various neural micro-environment developed.  
3. Develop mathematical tools for testing calcium dynamics 
iv 
4.  Study short term and interactions of novel biomaterial (CuHARS) used for tissue 
engineering in brain cell micro-environments (Ca+2 signaling as an indicator of cell 
“health”) 
To do so, tissue engineered microenvironments were constructed to test the effects 
of the glial cell density have on calcium information processing. We investigated the 
response of glia rich, mildly glia depleted, partially depleted, and severely depleted 
neuronal cultures to sub-maximal (nM to µM) glutamate concentrations using calcium 
imaging. This was used to assist in predicting and interpreting chaotic neural networks 
experimentally.  Anti-mitotic agents, cytosine arabinoside (AraC), or 2-deoxy-5-
fluorouridine (FdU) were used to inhibit proliferating glia and develop the three classes of 
glia density. Imaging was done with Fluo 3/AM, nine to fourteen days after plating. 
Neuronal cultures severely depleted (greater than sixty percent depletion) of glia responded 
to increasing glutamate additions with large, slightly unsynchronized responses with the 
greatest area under the curve (AUC) observed which returned to baseline the slowest of the 
three micro-environments developed. Cultures partially depleted (thirty to sixty percent 
depletion) of glia, responded to increasing glutamate addition with mid-sized, 
synchronized responses with lower AUC than cultures with severely depleted glial cells. 
Mildly depleted cultures behaved similarly to glia rich cultures. The difference between 
their AUC was not statistically significant. Studying how the brain behaves in altered 
systems, such as in glia depleted micro-environments will help us explore cell loss in the 
brain and develop more targeted protective strategies. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Project Overview 
Disorders of the brain and central nervous system account for more hospitalizations 
and loss of productivity than any other group of diseases including cancer and heart disease. 
In 2006, the World Health Organization (WHO) estimated that over one billion persons 
were affected directly or indirectly by neurological disorders ranging from epilepsy and 
Alzheimer’s disease to migraine headaches and stroke (1).  
The uniqueness and variance of each higher brain makes neuroscience a very 
widely studied scientific field. A precise pre-specified point to point description of the 
wiring of each section of the brain has yet to be discovered. There are generalities however, 
which are currently being studied. Anatomical and physiological interactions between 
neuronal and non-neuronal cells, like astrocytes (2) and microglia (3) are being studied, 
and many insightful discoveries have been made in recent years. Our lab has been using 
calcium signaling as an indicator of interactions between brain cells in culture. This project 
is a continuation of our long-standing interest in brain cell calcium dynamics with 
engineered environments coupled with applied mathematical tools and computerized 
programs which will assist in broadening our understanding of processing dynamics in the 
2 
neuronal circuit. We wish to gain insight into neurological diseases linked to altered glial 
cell densities and the resulting deregulated homeostatic calcium levels.  
1.2 Overview of the Nervous System 
Studies of the nervous system date back to the middle of the nineteenth century 
when neuroanatomists studied the morphology, cellular structure, and circuitry of the brain. 
Scientists were also interested in understanding the chemical composition and bioelectric 
properties of the nervous system with the goal of linking all these properties to specific 
phenotypic expressions. Over time and many experiments later, neuroscience  is now 
described as a data rich and theory poor discipline (4). Many breakthroughs have been 
made, but we have not been able to develop molecule to behavior definitions for behavioral 
expressions and neurological conditions such as Alzheimer’s and Parkinson’s disease. 
Although lots of data has been generated, the neuronal network level of neuroscience is 
data poor (4).  To make some headway in understanding the many complexities of the 
nervous system at micro and macro scales requires new computational and experimental 
techniques and tools. These tools will be vital for obtaining and analyzing data at the 
various levels.  
Our nervous system consists of many connections that send signals throughout the 
body to control several voluntary and involuntary actions. The nervous system is made up 
of the central and peripheral nervous system. The central nervous system (CNS) comprises 
the brain and spinal cord and the peripheral nervous system (PNS) consist of nerves and 
ganglia outside of the brain and spinal cord. The brain serves as the central organ of the 
nervous system and is involved in regulating many significant processes needed for the 
healthy functioning of the human body. 
3 
1.3 Neural Circuits 
The brain is made of copious interconnected neural microcircuits, each made up of 
neurons, glial cells, and synapses. The neurons are the major processing units of the brain 
and glial cells perform many regulatory and supportive functions in the central nervous 
system (CNS). These heterogeneously shaped, highly secretory active cells are sometimes 
referred to as the basic building blocks of the nervous system. Neurons are interconnected, 
highly differentiated, bioelectrically driven, cellular units that communicate via 
electrochemical signals that are generated and propagated via several mechanisms.  
These cells are classified in many ways ranging from their function (sensory, motor, 
interneuron) to the neurotransmitter synthesized and released by that cell (cholinergic or 
glutaminergic neurons) to something as simple as their morphology (pyramidal neurons). 
Typically, neurons can be separated into three main groups: inhibitory neurons (e.g. GABA 
interneurons), excitatory neurons (e.g. pyramidal neurons using glutamate) and 
neuromodulatory neurons that are involved in neurotransmission.  Neurons are polarized 
(consist of various sub-cellular domains with varied functions) cells made up of three main 
components, the cell body, axon, and dendrites.  
There are precise cytological characteristics associated with the secretory property 
of neurons such as large nuclei, substantial amounts of Golgi clusters and many smooth 
and rough endoplasmic reticulum. Each component of the neuron (axon, cell body and 
dendrites) are rich in microtubules that support the elongated structures (axons and 
dendrites) and facilitate the movement of essential substrates between the cell body and the 
elongated structures. The dendrites are branched treelike structures extending at the end of 
the axons or cell body which ramify over certain volume of grey matter. Figure 1.1 shows 
4 
three distinct types of neurons classified by morphology and location (pyramidal and 
purkinje, respectively) 
 
 
Figure 1-1: Diagram showing different types of neurons. (Left) A purkinje cell     of 
the cerebellar cortex and (right) a pyramidal neuron of the neocortex. (5). 
 
Non-neuronal cells include microglia, astrocytes, cells that make up the 
vasculature of the brain, cells of the choroid plexus, and meninges, the sheets of 
connective tissue that cover the surface of the brain and comprise the cerebrospinal 
fluid-containing envelope that protects the brain within the skull. There are many glial 
cells in the brain, with many estimates indicating at least as many as the number of total 
neurons (5). The main types of glial cells found in the CNS are astrocytes, 
oligodendrocytes, and microglia. Schwann cells are the predominant glial cells in the 
5 
PNS. The two most abundant glial cells in the CNS are astrocytes and microglia. The 
first description of glial cells was made in 1846 by a German Rudolf Virchow, who 
named them neuroglia meaning “nerve glue”.   For decades, these glial cells were 
thought to play passively supportive roles to neurons, however, recent evidence 
strongly suggest that these cells are actively involved in signal transmission and 
processing(6). This evidence has introduced a new idea that the brain is not only an 
array of interconnected neural networks but numerous integrated circuits of neurons 
and glia(7).  
Astrocytes are the most abundant multifunctional glial cells in the CNS (8); 
collectively called astroglia and are found mostly between the vasculature and the 
neuron or surrounding synapses. They play a significant role in brain homeostasis, via 
several metabolic processes established with neurons such as, removal of excessive 
extracellular neurotransmitter via uptake, break-down and recycling; and supplying 
neurons with energy metabolites. Gap junctions extensively couple these astroglia to 
form a functional syncytium that facilitates exchange between neighboring cells. 
Astrocytes signal and sense changes in the synapse via regulated pathways of 
neurotransmitter release, they also control its ionic environment. One of these 
regulatory pathways is illustrated in Figure 1-2. 
6 
                        
Figure 1-2: A simplified schematic illustrating the positive: negative feedback system 
of glutamate transmission and re-uptake within the synapse 
 
 
 Astrocytes also regulate neurotransmitter release and uptake by removing and 
recycling neurotransmitters that are released in the synapse which prevents 
excitotoxicity (uncontrolled neuronal stimulation). The uptake of neurotransmitter by 
astrocytes also modifies the signal strength from one neuron to the next. It is now known 
that astrocytes outnumber neurons within the brain; however, the ratio of the two cell 
types varies with location and species. Astrocytes are also known to have large 
glycogen deposits, which allow them to produce lactate, an energy source for neurons. 
Furthermore, astrocytes maintain proliferation abilities, making them easy to work with 
in cell culture. Recently, a growing number of researchers have found that astrocytes 
are also excitable cells (contrary to the belief that only neurons were excitable) and play 
an important role in brain information processing (9).  The main mechanisms 
7 
modulating the tripartite synapse are as follows: neurotransmitters (glutamate), released 
from presynaptic neuron during its activation, are bound to the metabotropic glutamate 
receptors (mGluR) on the astrocytes adjacent to synaptic terminals. This causes the 
synthesis of the second messenger, inositol (1,4,5)-trisphosphate (IP3) and the 
movement of calcium from the endoplasmic reticulum (ER) to the cytoplasm. The 
increased cytoplasmic calcium also takes place in nearby astrocytes as intercellular 
calcium waves that take place with the passage of second messengers through gap 
junctions. Due to the increased intracellular Ca2+ concentration, the astrocyte releases 
gliotransmitters, such as glutamate (glu) and ATP into the extracellular space and 
thereby can regulate pre- and postsynaptic neurons. 
Microglia are not as well described as other brain cells; discoveries have shown 
that these cells are more than likely from mesodermal origin. Microglia are the resident 
macrophage-like cells in the brain and function as the endogenous immune system of 
the CNS. These cells originate from bone marrow derived monocytes that enter the 
brain during the developmental stage. Once the blood brain barrier is formed, they 
become the exclusive immune cells of the brain. Microglia are evenly dispersed 
throughout the brain and can phagocytose, migrate, and proliferate as the need arises. 
Microglia are typically in a quiescent state characterized by small processes. In this 
basal or resting condition, microglia survey the surrounding environment with their 
ramified morphologies used for dynamic surveying movements. During periods of 
intracerebral inflammation (e.g., infection, certain degenerative diseases, or traumatic 
injury), activated microglia extend more processes that are notably thicker, which aids 
the cell in detecting pathogens. Microglia also have an amoeboid- like state which is 
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associated with its role as a phagocytic cell. In addition to the recruitment of microglia 
to sites of intracerebral inflammation, circulating macrophages and other white-blood 
cells enter the brain via endothelial signals to remove necrotic tissue or to defend against 
the microbial infection. Under normal conditions, microglial surveilling processes 
interact with synaptic structures (Figure 1-3). 
 
 
Figure 1-3: Dynamic interaction of microglial processes with tripartite synapse. (A)  
Microglial processes (red) dynamically contact the cellular compartments of the 
synapse pre- and postsynaptic neuronal terminals (in brown) as well as the 
enwrapping perisynaptic astroglial process (in blue) (10). (B) The electron micrograph 
(EM) specifically shows a microglial process (m) contacting both the pre- and 
postsynaptic compartment. The EM image is modified from (11). 
 
 
 
The synapse is made up of three components: a pre-synaptic neuronal element, a post-
synaptic neuronal element, and the synaptic cleft. The presynaptic element is a 
specialized portion of the pre-synaptic neuron’s axon, the synaptic cleft is the space 
between the pre and post synaptic elements and the post synaptic element is a 
specialized portion of the post synaptic somato-dendritic membrane. The pre-synaptic 
part of the axon is identified by the formation of vesicles and thickening at the active 
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site, the post synaptic site is also identified by thickening. If the thickening at the pre 
and post synaptic membrane is equal the synapse is referred to as symmetric when the 
post synaptic active site is thicker it is called asymmetric. Astrocytes are generally 
described as synaptic support cells (12) as they remove neurotransmitters such as 
glutamate and ions from the synapse after synaptic transmission from neuron to neuron 
takes place. Recently, evidence suggests that they play a more active role in synaptic 
transmission. One study showed evidence of enhanced synaptic activity by retinal 
ganglion cells (RGC) cultured with astroglial cells as compared with RCGs grown in 
purified cultures. In fact, in the purified cultures, little synaptic activity occurred (12). 
1.4 Neuron-Glia Interactions 
Neuronal networks are the organizational matrix that connects neurons to larger 
organ systems and without understanding how these networks function, it is difficult to 
explain how the larger systems communicate. The cells in the brain form microcircuits 
that communicate via electrochemical signals. One example of this signal transduction 
is shown in Figure 1-4. 
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Figure 1-4: Diagram showing one example of the coordinated action of neuron-glia 
interaction in the CNS (13) 
 
 
 
These circuits constitute the structural basis for brain function. Neural circuits can 
be categorized by the number of connections; macro-circuits comprise groups of neurons 
projecting from one part of the brain to another and micro-circuits involve local neuronal 
connections with a brain region. Detailed studies micro and macro circuits are essential in 
understanding the neural basis for cortical function in healthy and diseased brains. 
Mammalian brains contain neurons as numerous as one hundred million to one hundred 
billion depending on the species. Increasing evidence demonstrates the existence of 
bidirectional communication between neurons and their surrounding glial cells. 
Neurotransmission in neurons can illicit an increase in intracellular calcium concentration 
in adjacent glial cells. Activated glia can in turn release neurotransmitters that can feed 
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back to neuronal synaptic elements thus regulating the postsynaptic neuronal excitability 
and modulating neurotransmitter release from presynaptic terminals. Alterations in glial 
density may elicit profound changes on the functionality of their associated neuronal 
circuits and cause nerve cell damage.  
1.4.1 Glia and Glutamate Transmission 
Glutamate is one of the most important excitatory neurotransmitters responsible for 
brain homeostasis. It excites the neuron in part by causing large dynamic changes in 
intracellular calcium concentration. This neurotransmitter is clinically relevant because, 
elevated glutamate concentrations in the extracellular space are toxic. 
 One signaling pathway of interest is the release and uptake of glutamate and the 
cascade of electrochemical events that ensue. Upon release from the pre-synaptic 
membrane, glutamate is bound by receptors on the post synaptic membrane which causes 
an influx of calcium ions in the post synaptic neuron on which the glutamate is bound. This 
calcium influx, if sufficiently strong, initiates an action potential which relays an electrical 
signal to the post synaptic neuron. This signal can be propagated from neuron to neuron in 
very small to very large networks. The excess glutamate in the synapse is removed and 
recycled by the astrocytes. Astrocyte uptake and recycling prevents excitotoxicity which 
can cause seizures. Glutamate is also removed from the synapse via several high affinity 
glutamate transporters in presynaptic terminals. Approximately five to fifteen mmol of free 
glutamate per kg weight is present in the brain (14). This is more than one thousand times 
the amount needed to activate glu receptors therefore most of the glu in the brain is stored 
in intracellular compartments and there are many mechanisms to regulate extracellular 
glutamate levels. 
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As mentioned earlier, microglia are the innate immune cells of the brain and are 
involved in all CNS diseases. In pathological conditions, these cells are converted from 
their surveillant state to an activated state that operates within the diseased conditions. 
Microglial cells express various receptors for neurotransmitters, neuromodulators, and 
neuropeptides to sense neuronal activity. Scientists have found that cultured microglia 
express adrenergic receptors, metabotropic and ionotropic glutamate and γ-aminobutyric 
acid (GABA) receptors, dopamine receptors, bradykinin receptors, and several types of 
purinoceptors(10). In different pathological states, microglia gain distinct functional 
characteristics that change as the disease progresses. One such characteristic is their ability 
to contact injured neurons directly and remove synaptic connections in a process called 
synaptic stripping. This leads to desynchronization of neuronal circuits but also prevents 
the spread of the harmful effects. In some instances, entire dendritic trees can be removed. 
As part of the cascade of events taking place after microglial activation, substances such 
as reactive oxygen species, cytokines, or growth factors, which influence the pathological 
process during the acute and chronic phase as well as during subsequent regeneration are 
released. Even in their “resting” state, it has been shown that microglial processes are 
motile and as such, this state is better described as being a “surveillant” state. Fontainhas 
et al. found that activity mediated by GABAergic and glutamatergic mechanism regulate 
this movement of processes in the surveillant state (15).  
1.5 Neural Calcium Dynamics 
Calcium ions are involved in many functions of the nervous system, from 
neurotransmitter release to intracellular signal transduction (Figure 1-5) (16). 
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Figure 1-5: Diagram showing signal transduction by voltage gated Ca2+ channels (17) 
 
 
 These ions initiate specific intracellular signals that controls certain neuronal 
functions (18). Intracellular calcium concentrations lie in the 100 nM range under normal 
resting conditions due to calcium buffering molecules and sequestration into intracellular 
calcium stores (19). Electrochemical signals travelling along excitable cells are facilitated 
by calcium ion (Ca2+) fluxes through calcium channels. This phenomenon translates into 
varying functional outcomes. 
Calcium influx contributes to propagation of electrical signals and acts as a 
secondary messenger that activates several regulatory pathways. Many neuronal signaling 
pathways directly or indirectly increase cytosolic calcium concentration. Calcium in its 
ionic form is very dynamic, especially in excitable cells such as brain or muscle cells. These 
ions move from high extracellular concentrations to low intracellular concentrations where 
calcium ions are used as secondary messengers initiating G-protein dependent cascades. 
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These signals are involved in many biological processes within the neuronal circuit, 
including, gene expression, synaptic plasticity, neurotransmitter release, neurite outgrowth 
during development, learning, plasticity and apoptosis(20, 21) . Calcium imaging in the 
neuronal unit is essential since calcium signals are highly specific in well-defined cellular 
sub-compartments(18). 
Ca2+ channels in many different cell types are activated by membrane 
depolarization and mediate Ca2+ influx in response to action potentials and sub-threshold 
depolarizing signals. Ca2+ entering the cell through voltage-gated Ca2+ channels serves as 
the second messenger of electrical signaling, initiating many different cellular events (17). 
In cardiac and smooth muscle cells, activation of voltage gated calcium channels results in 
contraction by increasing intracellular (cytosolic) calcium concentration. In skeletal muscle 
cells, these Ca+2 channels interact directly with ryanodine- activated Ca+2 release channels 
in the sarcoplasmic reticulum.(17).    
Neuronal activity depends on a variety of voltage and ligand gated channels that 
are selectively permeable to ions such as sodium, potassium chloride, and calcium. Of the 
three aforementioned ions, calcium is the only one responsible for both altering membrane 
potential and cell signaling (22). Depolarization (voltage) induced calcium entry into 
neurons is primarily controlled by voltage gated calcium channels (Figure 1-6). 
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Figure 1-6: Diagram highlighting subunits of voltage gated calcium channels(17) 
 
 
 
 
Calcium influx along the electrochemical gradient takes place whenever these 
voltage gated calcium ions are opened. This causes a localized increase in intracellular 
calcium concentration that triggers several calcium dependent processes that include gene 
expression, neurite outgrowth, neurotransmitter release and the activation of calcium 
dependent enzymes such as protein kinase C (23).  
1.5.1 Voltage Gated Calcium Channels 
There are two types of voltage gated calcium (Cav) channels: high voltage activated 
(HVA) channels and low voltage activated (LVA) channels. HVA channels are opened by 
large membrane depolarizations and LVA channels are opened by smaller depolarizations 
near the resting potential of the neuronal membrane. HVA channels are heteromultimers 
made up of a pore forming Cav-α1 subunit that assemble with different Cav conjugates and 
calmodulin. LVA channels are made up of four major transmembrane domains that are 
connected by cytoplasmic linkers. These two Cav channels are shown in Figure 1-7. 
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Figure 1-7 : Diagram showing HVA and LVA channel subunit compositions (19) 
  
 
 
 
1.5.2 Ligand Gated Calcium Channels 
Ligand gated calcium channels can be activated by excitatory neurotransmitters 
such as acetylcholine, glutamate, adenosine tri-phosphate (ATP) and serotonin. The 
primary excitatory neurotransmitter, glutamate, mediates excitatory synaptic transmission 
in many regions of the CNS. Glutamate activates ionotropic glu receptor (GluR) channels 
and causes increased channel permeability to Ca2+ ions. The three main types of GluRs 
are N-methyl-D-aspartate receptors (NMDARs), α-amino-3-hydroxy-5-methyl-
isoxazolepropionate receptors (AMPARs) and kainate receptors (KARs). The N-site in 
NMDARs controls channel conductance and calcium permeability. Glutamate – mediated 
calcium entry into neuronal cells increases intracellular calcium at a wide temporal and 
amplitude range. 
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While the exact mechanism is not fully understood, it is believed that NMDAR 
mediated intracellular calcium increases can induce long term potentiation (LTP) or long 
term depression (LTD) of the post synaptic response (24). Aside from initiating LTP and 
LTD, it has been discovered that NMDAR mediated intracellular Ca2+ elevation also 
affects the NMDAR channels themselves. Ca+2 entry facilitated by NMDARs is sufficient 
to provide feedback inhibition of slow excitatory post synaptic currents (EPSC)(25),(26, 
27). 
1.5.3 Glutamate Receptors involved in Calcium Signalling 
Glutamate transporters are responsible for many important processes involved in 
synaptic signaling. These transporters rapidly clear the synaptic cleft of released 
neurotransmitter (28) and are therefore involved in the negative feedback loop responsible 
for preventing excitotoxicity. Many types of glutamate receptors are located on the 
neuronal cell membrane. 
AMPA receptors on the post-synaptic membrane are responsible for plasticity and 
synaptic transmission. They can also be glutamate receptors and cation channels. Long 
Term Potentiation is one of the most studied aspects of plasticity and can be activated only 
when glutamate is bound to the AMPA and the NMDA receptors (29-31). The kainate 
receptor is found on both the pre- and post-synaptic membrane and acts as a modulatory 
factor on the inhibitory neurotransmitter Gamma-Aminobutyric acid (GABA) through the 
presynaptic membrane. This has been confirmed as selectively blocking glutamate 
transporters enhances metabotropic GluR ESPC.  
Metabotropic receptors are indirectly linked to ion channels through signal 
transduction pathways which are usually G proteins. These receptors initiate a cascade of 
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events involving secondary messengers that opens specific ion channels. Neuronal and 
glial glutamate transporters are distributed on the membranes surrounding excitatory 
synapses. GLT-1 and GLAST are glutamate transporters found on astroglial cells and 
distributed at varying densities depending on the localized brain region. Figure 1-8 is a 
schematic of the different receptors involved in calcium signalling. 
 
 
Figure 1-8 : Diagram showing receptors involved in calcium signaling on neuronal and 
glial membranes: purple (NMDA), blue (AMPA), green (KA), pink (GABA), green 
(mGLUR 1/5), blue (mGLUR2/3), and burgundy (mGLUR 4/7/8) (32). Calcium is a key 
signaling ion involved in memory and learning with NMDA receptors on the neuronal 
membrane (33). 
 
 
 
1.5.4 Calcium Mediated Cell Death 
There are many cellular mechanisms that precede cell death such as, necrosis and 
apoptosis. Each mechanism can be identified due to differences in their morphological and 
biochemical expression. In 2009, the Nomenclature Committee on Cell Death proposed 
criteria for the definition of twelve cell death modalities (34). These classifications are: 
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apoptosis, necrosis, autophagy, cornification, mitotic catastrophe, anoikis, excitotoxicity, 
Wallerian degeneration, paraptosis, pyroptosis, pyronecrosis and entosis. The most 
extensively described cell death modalities are apoptosis, necrosis, and autophagy. The 
term “apoptosis” was coined by Kerr et al. (35) and has been defined as a form of cell 
suicide since death is controlled by active intracellular processes. This is morphologically 
characterized by rounding up of the cell, retraction of pseudopodes, reduction of cellular 
volume (pyknosis), chromatin condensation, nuclear fragmentation, and plasma membrane 
blebbing. The cell fragments break up into membrane enclosed fragments which are then 
recognized and destroyed by macrophages or neighboring cells. Apoptosis is usually 
referred to as “programmed cell death” and occurs during development as a mechanism to 
control cell populations. The execution of this process is mediated by several enzyme-
mediated systems that are activated through elaborate signaling pathways. 
The calcium ion is a key player in homeostasis and has been implicated in both the 
initiation and effectuation of cell death (36) as well as cell growth (37). Perturbation of 
Ca2+ homeostasis in cancer cells has been linked with sustained cell proliferation and the 
inhibition of cell death through the modulation of Ca2+ signaling (37). Characterization of 
the signaling pathways involved in apoptosis revealed that a Ca2+-calpain complex is 
significantly involved in the processing of the mitochondrially localized factor called 
Apoptosis Inducing Factor (AIF) (Figure 1-9). 
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Figure 1-9 : Diagram showing the involvement of calcium/ calpain in AIF processing   (36) 
 
 
 AIF is a key component in the death of certain cells such as neurons and some 
cancer cells (38). Compounds that perturb intracellular Ca2+ homeostasis make the AIF-
mediated pathway the predominant mechanism of subsequent apoptosis. This event is a 
frequent component of cell death signaling, particularly in ischemia-reperfusion injury and 
after treatment with toxic drugs. 
 NMDARs are sometimes excessively stimulated by glutamate; this can lead 
to an increase in calcium influx which in turn causes neuronal damage and subsequent 
excitotoxicity. Glial cells are responsible for removing the excess glutamate from the 
surrounding environment but can only take up a specific amount of glutamate. Many 
diseases are caused by cell death triggered by excessive calcium influx such as, 
Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). 
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1.5.5 Calcium Dependent Excitotoxicity 
Excitotoxicity is one of the key mechanisms underlying neuronal damage during 
CNS events such as ischemia, traumatic brain injuries and other neurological disorders.  
Ca2+ ions are ubiquitous intracellular messengers governing numerous cellular functions 
such as the control of cell growth and differentiation, membrane excitability, exocytosis, 
and synaptic activity (39). As a result, neurons need to efficiently regulate the intracellular 
Ca+2 to achieve a sufficiently high signal to noise ratio for proper calcium signaling to 
occur. 
The free calcium concentration needs to be very low (~10nM) when the neuron is 
not signalling so that small or localized calcium increases can trigger physiological events 
such as the activation of ion channels. To do so, neurons have developed complex 
homeostatic mechanisms that control both the concentration and the localization of calcium 
at any given time. These mechanisms consist of complex interactions between four broad 
categories of events namely: Ca+2 influx, buffering, internal storage, and efflux (shown in 
Figure 1-10). 
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Figure 1-10: A schematic representation of Ca2+ homeostasis in neurons (39) 
 
 
 
Under physiological conditions, a complex yet delicate connection between these 
processes allows the regulation of multiple Ca+2 dependent signaling cascades within one 
cell. Research shows that excessive Ca+2, exceeding the capacity of these regulatory 
mechanisms can results in the over-activity of certain processes which would either be 
dormant or normally operate at low levels. When this happens, enzyme- mediated 
processes and other metabolic machinery damage neurons and subsequently leads to the 
formation of toxic products which leads to cell death.  
  Metabotropic receptors activated by glutamate are not directly associated 
with an ion channel pore but mediate their actions through guanine triphosphate (GTP) 
binding protein dependent mechanisms leading to a mobilization of Ca+2 ions from internal 
stores such as the endoplasmic reticulum by inositol triphosphate formation. Dr. Olney 
coined the term excitotoxicity when he observed neurodegeneration caused by EAAs such 
as glutamate (40).  Since then, it has been discovered that excitotoxicity is a key mechanism 
23 
in many neuro-pathological states such as ischemia (stroke), nervous system trauma, 
epilepsy, and certain chronic neurodegenerative disorders.  
 Excitotoxicity is a consequence of excessive and sustained synaptic release of 
glutamate. Studies have shown that the use of glutamate receptor antagonists such as MK-
801 and 2-amino-7- phosphonohepatonic acid resulted in neuroprotective activity (16).  
Kass and Lipton reported that attenuating synaptic transmission and post synaptic receptor 
binding of glutamate via magnesium blocking resulted in a reduction of hypoxic/anoxic 
neuronal death (41). Practically, every glutamate receptor subtype has been implicated in 
mediating neurotoxicity. Although the entire molecular basis of glutamate toxicity has not 
been fully described, there is general agreement that it is largely Ca+2 dependent. It has also 
been discovered that the NMDA subtype of glutamate receptors plays a key role in 
mediating at least certain aspects of glutamate neurotoxicity, owing to their high Ca+2 
permeability. 
1.5.6 Glutamate Induced Calcium Fluorescence 
Glutamate homeostasis involves neuronal release, neurotransmission, and glial 
uptake. Neuronal release of glutamate is stochastic and as a result exogenous glutamate is 
introduced to cells in vitro. When this is done, we expect calcium to enter the neurons as it 
is an excitatory neurotransmitter (42). There is a directly proportional relationship between 
glutamate stimulation and the probability that neurotransmission takes place. During 
calcium imaging experiments, calcium influx is expressed as an increase in fluorescence. 
1.5.7 Calcium Imaging 
Over the past few decades, much of the research on neuronal properties and overall 
brain function was derived from recording single neuron electrical signals. This method is 
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comparable to looking at a movie scene with a straw, many crucial details are left out and 
there are many opportunities for error as a result. Recently, optical methods have been 
developed to observe higher- order interactions between hundreds of cells and this 
facilitates studying neural networks as well as single cells simultaneously. One such 
method is calcium imaging. Calcium imaging is a common technique used to detect and 
measure calcium signals in cultured cells (43). This technique uses calcium indicator dyes 
which are mainly organic molecules that respond to binding Ca2+ ions by changing their 
spectral properties.  
The calcium ion is a universal secondary messenger involved in specific and 
selective regulation of cellular process such as muscle contraction, fertilization, synaptic 
transmission, cell division and blood clotting. Calcium ions play a significant role in 
neuronal signaling and generate intracellular signals that elicit various responses. It has 
been shown that changes in intracellular calcium concentration is a mechanism for cell 
signaling in many brain cells (44).  These intracellular changes are usually visualized as 
wave-like transient (small or brief), sustained (prolonged calcium increase) or oscillatory 
(repeated brief calcium increases) signals throughout specific cellular regions or between 
groups of adjacent cells.  Ca2+ cannot be visualized directly in living cells as it does not 
have any intrinsic fluorescent properties. To image intracellular calcium changes, specific 
molecules expressing optical properties dependent on intracellular Ca2+ concentrations are 
used. Calcium signals differs in their timing, sub cellular location and amplitude and these 
properties are related to explicit functions. Calcium signaling is essential for normal brain 
function, however, excessive and sustained intracellular Ca2+ levels are associated to 
neuronal injury and cell death (45).  
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Calcium imaging is one of the most widely used techniques in neuroscience today 
as intracellular calcium concentration is associated with physiological and 
pathophysiological activity of neurons. Calcium sensitive dyes are used as tools for 
studying calcium signaling in various cell types. From their introduction by Tsien et al 
(46), calcium indicators have been used to study calcium signaling in a plethora of cell 
types and applications. There are two main types of Ca2+ indicators, genetically encoded 
fluorescent proteins and chemically engineered fluorophores (47). The fluorescent 
properties of the indicators are altered when bound to freely diffusible calcium and it is 
therefore possible to monitor intracellular calcium processing in live single cells and multi-
cellular networks. 
Many advances have been made since the introduction of these indicators. Our 
emphasis will be on fluorescent acetoxymethyl (Fluo-AM) dyes. The cell membrane is 
impermeable to most free Ca2+ indicators therefore varied methods are used to facilitate 
their entrance.  Once inside the cell, esterases cleave the AM groups and release the 
hydrophilic fluorophore which can then bind to the free Ca2+. To choose an appropriate 
indicator, the imaging hardware and software available, the importance of qualitative 
versus quantitative data and the potential problems that may be encountered should be 
considered. Fluo-AM dyes are single wavelength indicators that change their fluorescence 
properties when bound to free calcium. 
One drawback of using these dyes is that it is difficult to distinguish between 
fluorescent intensity changes caused by a change in [Ca+2] or intensity variations caused 
by a disparity in dye loading. To combat this problem, the fluorescent signal (F) is typically 
expressed relative to the initial fluorescence intensity (Fo) denoted by F/Fo or ΔF/Fo if the 
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change in fluorescence is measured.  This approach does not account for changes in 
fluorescence caused by extrusion or bleaching and as such, care needs to be taken when 
performing an experiment. 
The calcium concentration to be measured during the experiment needs to be 
considered when choosing a suitable indicator. The dissociation constant (denoted by Kd) 
of the indicator should be near the midpoint of the [Ca2+] range to be detected.  For large 
concentration ranges, low affinity indicators are used, and high affinity indicators are used 
for minor changes in [Ca2+]. Selecting an indicator that is excited by red or green light is 
preferred to UV because UV light has more energy than the visible spectrum. However, 
prolonged exposure to any type of light will result in cell death. Control experiments 
studying the impact of excitation light to the cells should be done.  Before performing 
experiments with stimuli, an identical experiment with the same duration and light intensity 
should be done to ensure that the indicator-cell combination remains stable.  Studies have 
shown that some indicators buffer Ca2+ therefore excessive loading of cells can 
significantly reduce the Ca+2 signal (48).  Calcium imaging is a useful tool for studying 
signal transduction in neuronal cultures and typically works robustly for primary cells. The 
indicators used are sufficiently bright with exceptional signal to noise ratios. For this 
project Fluo3/AM dye was used. Fluo3/AM binds non-covalently to calcium and therefore 
has a dissociation constant. The free calcium concentration can be calculated using a single 
wavelength calcium indicator using the following formula (48): 
 
[𝐶𝑎2+]𝑓𝑟𝑒𝑒 = 𝐾𝑑 [
𝐹−𝐹𝑚𝑖𝑛
𝐹𝑚𝑎𝑥−𝐹
]                                                           Eqn. 1-1 
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where F is the fluorescence of the indicator at a certain time point, Fmin is the minimum 
fluorescence due to calcium chelation and Fmax is the fluorescence of the calcium saturated 
probe (found using calcium ionophores such as ionomycin). 
1.6 Neurological Diseases Associated with Glial Anomalies 
As mentioned throughout this chapter, we are interested in studying how glial 
density is involved in glutamate re-uptake and recycling as this relates to synaptic activity 
(calcium signalling). Since the brain comprises several interconnected networks, 
disturbances in one area leads to many secondary manifestations and the development of 
various neurological diseases (Figure 1-11). 
 
 
Figure 1-11: Calcium deregulation leading to neurodegenerative diseases (49). 
 
 
 
1.6.1 Epilepsy 
Astrocytes are critically important in the regulation of extracellular glutamate levels 
in the CNS due to the abundant expression of high affinity glutamate transporter proteins 
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on the cell membrane (50). It is estimated that approximately 80–90% of extracellular 
glutamate uptake is done by astrocytic glutamate transporters (51).  Accumulation of this 
neurotransmitter has harmful effects on the function and survival of neurons. Many 
neurological diseases, particularly epilepsy, are accompanied by astrocyte dysfunction 
which leads to the development of over-excitable neurons. Rapid growth of reactive 
astrocytes (gliosis) is a common feature of temporal lobe epilepsy (TLE). This gliosis is 
associated with delayed re-uptake of extra-cellular glu (52). Early studies evaluating the 
effects of glu and glu analogues on the development of epileptic seizures in lab animals 
indicated that glu is a critical player in the development of this pathophysiology (53). 
Numerous studies have been done subsequently and it is now generally accepted that 
glutamate dysregulation, specifically over-exposure of neurons to glu leads to 
excitotoxicity which if unregulated leads to epileptic seizures. Figure 1-12 shows some of 
the major metabolic pathways involved in normal brain glu homeostasis and some of the 
areas affected by epilepsy.  
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Figure 1-12: Diagram depicting some of the major metabolic pathways and tissue 
compartments involved in normal homeostasis of brain glutamate. The dashed frames 
indicate areas being affected in epilepsy  (51). 
 
 
 
1.6.2 Parkinson’s Disease 
Parkinson’s disease (PD) is the second most common neurodegenerative disease 
worldwide (54). It is currently an incurable disease with symptomatic manifestations 
ranging from tremors, bradykinesia and rigidity to amnesia, dementia, and many others. 
The causes of this disease are not fully understood, and no formal treatment has been 
developed to slow down its progression.  The core motor symptoms are attributed to the 
death of dopaminergic neurons located in the substantia nigra pars compacta (SNc), a small 
region in the mesencephalon. Several studies implicate disturbances in calcium signalling 
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as a cause. These studies link Ca2+ entry through Cav1 channels and the feed-forward 
control of mitochondrial metabolism to the development of PD (55). 
1.6.3 Major Depressive Disorder 
Major depressive disorder (MDD) is debilitating metal disorder that affects millions 
of individuals directly and indirectly (56). Postmortem studies have shown that reduction 
in astrocyte density and their related markers are key features in this disorder. This finding 
has also been found in rodent models of depressive-like behavior (57). As mentioned 
earlier, astrocytes are crucial in the uptake, metabolism and recycling of glutamate and 
glutamate transporters located on the astrocytic membrane (used as markers for astrocyte 
function) are also down-regulated in postmortem studies of patients with MDD.   
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CHAPTER 2 
 
TISSUE ENGINEERED MICROENVIRONMENTS 
 
2.1 Overview 
The goal of this chapter is to describe the methods used to develop neural circuits 
with quantifiable variations in glial cell densities. These variations are separated into three 
distinct categories: severely depleted, moderately depleted, and mildly depleted glial cell 
neural micro-environments. We hypothesize that the glial density will be reduced using 
anti-mitotic agents leading to fewer cells and changes in cell morphology.  
 
2.2 Background 
It is virtually impossible to look at all the neurons in the brain simultaneously, and 
as a result, scientists have begun exploring the idea of looking at neuronal circuits where 
the number of neurons in a circuit ranges between a few to many thousand cells. Many of 
the breakthroughs made in neuroscience are because of the piecemeal reconstruction of 
many neuronal circuits. Miniscule changes in neuronal circuits can elicit drastic 
physiological changes in an individual.  For decades, immortalized cell lines have been 
used as a tool in basic research. Over time, continuous passaging of cell lines facilitates 
genetic or phenotypic variations and the cells lose the original tissue properties.  Primary 
cells are more biologically relevant as they are derived directly from the human or animal 
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tissue via enzymatic or mechanical methods. These cells are physiologically and 
phenotypically more closely related to the tissue that they are extracted from than 
immortalized cell lines.  The cells can be grown either suspension or adherent. Throughout 
this study, adherent primary brain cells were utilized. Unlike cell lines, primary cells have 
limited lifetimes before reaching senescence. Also, neurons are very delicate cells therefore 
it is easier to perform experiments with the less fragile, pure glial cultures before the 
neuronal cultures.  Dissociated cortical neuronal cultures possess many distinct benefits for 
studying chemical and electrical signaling between neurons. The applications of these 
benefits include (but are not limited to) neural circuit models of development, memory, 
aging and disease.  
2.3 Primary Cortical Culture Protocol 
Cortical cells were obtained by performing cervical disarticulation of outbred 
Sprague-Dawley newborn rat pups (age ≤ 48hours) in adherence to protocols approved by 
Louisiana Tech University’s Institutional Animal Care and Use Committee (IACUC). Rat 
pups were decapitated, and the brain tissue was quickly removed and placed into dissecting 
solution consisting of Basal Media Eagle, (BME, Sigma) and 0.5% Penicillin Streptomycin 
(PS, Sigma).  
The cerebellum and meninges were removed, and the cortical lobes were then 
stored in an ice-cold dissecting solution. (An average of n=seven newborn rat pups were 
used for each culture set). After dissection was completed, the brain tissue was then 
aspirated with a 5ml pipette and placed into a 15ml conical tube with a complementing 
volume of Trypsin EDTA (volume determined by number of rat pups, Sigma) and inverted 
five times. Trypsin was then neutralized with Neuronal Culture Medium (NCM. Appendix 
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A) comprised of BME, Ham’s F-12K (ATCC), 10% Horse Serum, 10% Fetal Bovine 
Serum (FBS), glucose, glutamine and PS. The cells were then mechanically dissociated by 
trituration and allowed to form a brain cell supernatant for ten minutes. The supernatant 
was then aspirated and stored in a 15ml ice-cold conical tube. NCM was then re-introduced 
to the brain tissue and the process repeated thrice in total. The brain cell supernatant was 
centrifuged at 160 relative centrifugal force (rcf) at eight degrees Celsius for seven minutes 
to form a pellet.  
2.4  Development of Quantifiable Neural Cell Micro-Environments 
To study the effect of glial density on the calcium signalling capacity of neurons 
within a cell culture platform, we have employed the use of certain anti-mitotic agents to 
deplete the mixed culture harvested from brain tissue. We will be studying the effect of 
two specific chemicals, namely, Cytosine Arabinoside and 2-deoxy-5-fluorouridine (FdU). 
To establish cultures with varied cell densities, we performed several preliminary 
experiments using various concentrations to find the optimal concentrations needed to 
develop the three levels of depletion outlined above.  Figure 2-1 is a schematic briefly 
outlining each step in this process. 
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Figure 2-1: Schematic outlining the different steps used to develop various brain cell 
microenvironments.  
 
 
 
2.4.1 Developing severely depleted micro-environments using cytosine arabinoside                                    
Cytosine Arabinoside (AraC) is a chemotherapeutic drug used to treat certain brain 
cancers by slowing down the growth and spread of rapidly dividing cancer cells. This drug 
has also been used traditionally to establish primary cultures of neurons by killing the 
dividing, non-neuronal brain cells. This method is useful in mixed cultures, as neurons are 
post-mitotic and are therefore not targeted; thus, it can be used to eliminate the glial cells 
and establish “pure” neuronal cultures. AraC is a pyrimidine anti-metabolite that depletes 
proliferating cells by inhibiting deoxyribonucleic acid (DNA) synthesis (structure shown 
in Figure 2-2). 
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Figure 2-2: Structure of Cytosine Arabinoside (AraC) (58), 
 
 
Our lab uses an established protocol to develop severely depleted neural cell micro-
environments (59). After following the primary cortical culture protocol, the cells were 
treated with a 100x dilution of the anti-mitotic, AraC (1mM, Sigma) to deplete glial cells 
from cultures at four days in vitro. Cell cultures prepared using this method were 
determined to be at minimum, eighty percent depleted using a combination of staining 
methods and Image Pro Plus software for cell counting. The number of cells is recorded by 
calculating the average (mean) number of cells in ten images taken from the same well and 
this is done in thirty-two wells per experiment. These images are taken using a Leica 
inverted microscope and the coordinates for each image is retrieved using the Leica 
Application Suite software to ensure that each image is taken from a different area in the 
well. Four plates were used for each experiment and the experiment was repeated three 
times to ensure that the results were reproducible. Representative images of mixed cortical 
brain cell cultures with and without AraC are shown in Figure 2-3. 
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Figure 2-3: Images showing mixed cortical neuronal cultures with and without AraC 
treatment. A: Primary cortical cultures low in glia (AraC treatment) B: Primary cortical 
cultures high in glia (no AraC treatment). Error Bars = 100µm 
 
 
 
 The images reveal an increase in the cell area on the plate after treatment with 
AraC. The cells are less balled up and are spread out over the plate therefore increasing the 
area on the plate without increasing the cell volume. Each experiment was done in eight 
wells on a forty-eight well plate with four wells per condition. The data in Figure 2-4 is 
representative of one of the experiments. The average number of cells recorded in cultures 
treated and untreated with AraC were 27 and 269 cells respectively, with standard 
deviations of 5.24 and 24.38 respectively.  Each bar represents the average number of cells 
from a total of sixteen wells per condition.  
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Figure 2-4: Graph showing the effect of adding AraC on the number of cells within the 
mixed glial (astrocytes and microglia) cell cultures field of analysis. Data is shown as mean 
plus standard deviation (Error Bars = sd). 
 
 
 
This protocol was then repeated with pure astrocyte cultures which were derived using the 
method outlined in Figure 2-5. 
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Figure 2-5: Overview of the protocol for preparing mixed glial cell cultures and isolation 
of primary astrocytes. 
 
 
 
 
The mixed glial cell culture was checked using an inverted phase-contrast microscope 
fourteen to seventeen days after the initial plating, when astrocytes reach ~90% confluence. 
The microglia are growing above the single layer of astrocytes as small rounded cells. 
(Adjusting the fine focus of the microscope assists in distinguishing the different cell layers) 
as shown in Figure 2-6.  
 
 
Figure 2-6: Phase-contrast microscopy of: (A) primary astrocytes; (B) primary 
microglia; (C) mixed culture of astrocytes and microglia (41). 
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The cell culture flask was then placed on a flattened surface and gently tapped on the sides 
at the speed of forty-five times per minutes (Try to minimize the amount of foam generated 
when shaking the cell culture flasks). While tapping and shaking the cell culture flask, the 
centrifuge was prepared by setting the temperature to four degrees Celsius (Other settings 
used: 160rcf for 8 minutes). Using a centrifuge, it takes about twenty minutes to cool down 
from room temperature to four degrees Celsius. This may vary based on the type of 
centrifuge available, so it is important to ensure that it is ready for use at the appropriate 
temperature as you are isolating the cells to prevent any delays. The cell culture flask was 
then checked under the inverted phase- contrast microscope every three minutes to ensure 
that the monolayer astrocytes remained undisturbed and continued to adhere to the 
substratum of the flask. The detached microglia float in the media, while the astrocytes 
remain attached to the bottom.  
If attached microglia are observed, keep shaking the flasks until most microglia are 
floating. Using this method, after gentle shaking of the flasks for nine to twelve minutes, 
most of the microglia were removed without disturbing the adherent astrocytes. Note: If 
astrocytes are sheared from the bottom, immediately stop shaking the flasks. If the 
harvested cells are contaminated with significant amounts of astrocytes, this may be caused 
by two reasons: 1) shaking is too rigorous; 2) astrocytes are not sufficiently healthy to 
remain attached to the substratum of the flask. If astrocytes readily detach from the flask, 
consider changing fresh culture media more frequently (three rather than two times per 
week).  
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 After most microglia detach, the shaking (tapping) was stopped and the 
culture media was carefully aspirated and placed into a 15 or 50 ml conical tube (depending 
on the amount of media used) for culturing primary microglia if needed (Primary microglia 
media protocol: Appendix A).  Fresh media was then added to the astrocytes attached to 
the surface of the flask and placed in the incubator. The cells were then placed in the 
incubator for about twenty-four hours then removed and passaged by trypsinization. This 
protocol is ideal for the concomitant isolation of both microglia and astrocytes. The cells 
are then counted and re-plated for treatment or imaging. Using a combination of staining 
and Image Pro Plus software for cell counting the isolated astrocyte culture was found to 
be ~95% pure astrocytes.  
 The pure astrocyte cultures were treated with 10µM AraC and Figure 2-7 shows 
the results. Like the mixed glial cultures, the pure astrocyte cultures were depleted by at 
least 90% overall after addition of AraC. The average number of cells recorded in cultures 
treated and untreated with AraC were 24 and 234 cells respectively, with standard 
deviations of 2.22 and 14.60 respectively. 
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Figure 2-7: Graph showing the effect of adding AraC to the number of cells within the 
pure astrocyte culture’s field of analysis. (Error bars = Standard Deviation). n=16 
 
 
 
 As a last step for developing glia- depleted micro-environments mixed 
cultures with neurons and glia were also treated with AraC as follows. Briefly, once the 
cells were harvested from the cortical region of the rat pup brains and resuspended in fresh 
NCM, a cell count was obtained with a hemocytometer, the cells were then plated in a 
poly-L-lysine (PLL, Sigma) coated, 48 multi-well plates (cell culture treated, CellStar) at 
an optimal density of 100,000 cells per well. The cell cultures were maintained in 37 
degrees Celsius (◦C), five percent carbon dioxide, and humidified incubation. At four days 
in vitro, the cells were treated with AraC and media was changed every three to four days 
until nine days in vitro when the cells were stained and counted. The average number of 
cells recorded in mixed neuronal cultures treated and untreated with AraC were 140 and 
349 cells respectively, with standard deviations of 20.28 and 47.63 respectively.  Each bar 
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represents the average number of cells from a total of sixteen wells per condition. The 
results obtained are shown in Figure 2-8. 
 
 
Figure 2-8: Graph showing the effect of adding AraC on the number of cells within 
mixed neuronal culture’s (neurons, astrocytes, and microglia) field of analysis. (Error 
bars = Standard Deviation) n=16. 
 
It is important to note that AraC does not affect neurons, thus the number of cells 
in this last step will always be higher. To confirm that the AraC depleted the astrocytes in 
the mixed neuronal cultures as expected (same as pure astrocyte cultures), concurrent 
staining with 4,6-diamidino-2-phenylindole (DAPI) and glial fibrillary acidic protein 
(GFAP) was used to count the astrocytes only.  
The astrocytes depletion was found to be at least 85% in the mixed neuronal 
cultures. 
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2.4.2 Developing Micro-environments using novel method 
Literature indicates that the use of AraC to produce pure neuronal cultures may 
have harmful effects on the post mitotic neurons in a similar fashion to nerve growth factor 
(NGF) deprivation of neurons (60). A recently published article by Hui et al. described a 
method used to deplete astrocytes within the mixed cultures with minimal effects on 
neurons using fluoro deoxyuridine (61). FdU is an antineoplastic drug that inhibits 
thymidylate synthetase, blocks DNA synthesis and kills proliferating cells (62). We have 
developed a novel method using a modified version of this protocol to develop brain cell 
microenvironments categorized as mildly, moderately, and severely depleted. After 
preliminary experiments were completed to find the optimal concentrations to develop 
these quantifiable micro-environments, a modified protocol was developed. For our 
modified protocol, 0.01µM, 0.5µM, 1µM, 2µM and 4 µM concentrations of FdU was 
added at four days in vitro and incubated for twenty-four hours to kill the proliferating 
cells. Medium containing FdU was then replaced with fresh medium without FdU (old to 
new NC medium in a one to one ratio). Half of the medium was then replaced every five 
days until at least 14 days in vitro (DIV) before any treatment staining and cell counting 
was done.  Figure 2-9 shows the percent (%) depletion of astrocytes within mixed brain 
cell cultures treated with different concentrations of fluoro deoxyuridine.  
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The % depletion recorded in mixed neuronal cultures treated with 0.01,0.5,1,2, and 4 µM 
FdU are 23, 42, 63, 61, and 94 respectively, with standard deviations of 3.46,2.46, 1.74, 
1.63, and 0.20 respectively. 
 
 
Figure 2-9: Graph showing percent depletion of mixed neuronal cultures treated with 
different concentrations of 2-deoxy-5-fluorouridine. These values have been normalized to 
the % of the cell density of untreated cells. The data is given as the mean± sd of three 
independent experiments. Since the sample size varied for each experiment, the 
significance of changes in the treatment responses was assessed using the Tukey-Kramer 
multiple comparison test; differences were considered statistically significant at P<0.05, 
n•=18. 
 
 
2.4.3 Assessing Metabolic Activity of Various Brain Cell Micro-environments 
The MTT assay is a colorimetric assay which is used as a relatively high throughput 
(96-well plates) method of measuring cell viability by assessing the cell’s metabolic 
activity. This method has been accepted as a reliable way to examine cell proliferation and 
is based on the principle that most viable cells have constant mitochondrial activity. The 
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mitochondrial activity is measured by the cell’s ability to reduce the yellow tetrazolium 
salt MTT to purple formazan crystals (Figure 2-10)which are then dissolved for 
homogeneous measurement (63).  
 
 
Figure 2-10: Schematic showing the conversion of MTT (yellow) to Formazan 
(blue/purple) via mitochondrial reductases (64). 
 
 
 
After successfully developing the quantifiable brain cell micro-environments, the 
metabolic activity of each brain cell culture was evaluated using the MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium cell viability assay. This was done first 
with mixed glial cultures then pure astrocyte cultures and finally with mixed neuronal 
cultures. The results of these experiments are shown in Figure 2-11. The protocol for the 
MTT assay can be found in Appendix A. 
Cell survival was calculated using the following formula (63): 
𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 % =  
(100) ∗  
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠 − 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑚𝑒𝑑𝑖𝑢𝑚
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠 − 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑚𝑒𝑑𝑖𝑢𝑚
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                     Eq. 2-1 
Any change in mitochondrial activity can then be quantified using various 
spectrophotometric means. The survival % recorded in mixed neuronal cultures treated 
with 0.01, 0.5, 1, 2, and 4 µM FdU are 86.7, 69, 40, 39, and 5 respectively, with standard 
deviations of 5.58, 2.67, 3, 2.25, and 1.33 respectively 
 The data in Figure 2-11 is given as the mean plus sd of three independent 
experiments.  
 
 
Figure 2-11: Graph showing survival percent of mixed glial cultures treated with different 
concentrations of FdU. These values have been normalized to the percent of the cell density 
of untreated cells. Error bars = sd.  
 
 
 
Since the sample size varied for each experiment, the significance of changes in the 
treatment responses was assessed using the Tukey-Kramer multiple comparison test; 
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differences were considered statistically significant at P<0.05, n•=18. After assessing the 
MTT and the % depletion results, the microenvironments were categorized as follows 
(Table 2-1). 
 
 
 
Table 2-1: Neural Microenvironment Classification 
 
 Mildly Depleted Partially Depleted Severely Depleted 
FdU Concentration 
(µM) 
0.01 0.5 1,2,4 
% Depletion(x) x<30 30<x<60 x>60 
 
  
The hypothesis that the glial density will be reduced using anti-mitotic agents 
leading to fewer cells and changes in cell morphology was supported. Glial density was 
assessed using percent depletion after treatment with FdU and the cultures were 
categorized into three conditions: mildly, partially, and severely depleted cell cultures. The 
MTT assay was used to assess and quantify the metabolic activity of each condition and 
the results indicated that metabolic activity decreased as percent depletion increased as 
expected. The calcium imaging techniques used to study the calcium information 
processing of cultures in each category is discussed in the following chapter. 
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CHAPTER 3 
 
CALCIUM IMAGING  
 
3.1 Overview 
This chapter describes the accomplishment of the second goal of the overall project 
which is to use calcium imaging methods to analyze the calcium dynamics of various 
neural micro-environments. As previously mentioned, calcium imaging techniques were 
used to analyze the signal processing capacity of the quantified micro-environments 
described in chapter two. Calcium imaging is a widely used technique to investigate the 
calcium signal processing in neuronal cultures. We hypothesize that decreasing the glial 
cell density will affect neuronal calcium dynamics by increasing the amount of glutamate 
to which the neurons are exposed, and increasing the time taken for recovery.   
3.2 Calcium Fluorescence Imaging 
The goal of this procedure is to gain a better understanding of the effect that glial 
density has on the neuron’s capacity to recover from glutamate stimuli. An example of the 
raw data is given in Appendix B. Multiple experiments were performed utilizing different 
protocols. The protocols utilized were dependent on the substrate, cell type and stimulus 
added during imaging. During the experiments, primary cortical cells were on polystyrene 
surfaces with the Fluo3/AM calcium indicator and a 20X objective. The cells were imaged 
using an Olympus CKX31 inverted microscope with a 488nm excitation wavelength filter 
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over real-time at four seconds per frame with the InCyt Basic Im™ Imaging System 
(Intracellular Imaging Inc., Cincinnati, OH). A baseline recording (spontaneous 
oscillations prior to addition of stimulus) was obtained for 80 seconds, various glutamate 
concentrations were added to the imaged wells typically at intervals of 80 seconds, but this 
could be changed depending on the experiment without washing out the media between 
addition (illustrated in Figure 3-1) 
 
 
Figure 3-1: Stimulation protocol for most experiments. Glutamate is added into the        
experiment at equally defined times and at three concentrations. Each concentration is 
added at a set treatment number without washing the glutamate out of the well. 
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3.2.1 Preparation and Loading of Calcium Dye  
The cortical cultures were images eight to nine days in vitro (DIV), by incubating the cells 
in a loading solution (Appendix A) for 45 minutes to an hour. The cells were then washed 
and recovered in pre-warmed Locke’s solution and re-incubated for 30 minutes. While the 
cells were recovering, fresh glutamic acid solutions of three concentrations 250, 500, 
750nM (Sigma Aldrich) were prepared in Locke’s solution. 
Locke’s Solution:  
Locke’s solution is a solution used in fluorescence experiments because it lacks serum and 
phenol red (found in complete media) thus eliminating auto-fluorescence or quenching of 
the calcium dye (43). Locke’s solution is made up of sodium chloride, potassium chloride, 
calcium chloride, calcium bicarbonate, glucose, Hepes buffer and sterile deionized water 
(Appendix A). 
Glycine Bath: 
Glycine is a co-agonist of the NMDA receptor and assists in preventing excitotoxicity of 
neuronal cells (65). A 10µM glycine (Sigma) bath (also called recovery solution) was 
prepared with Locke’s solution as the solvent. This solution was warmed and introduced 
to the experimental wells after the cell had fully recovered from exposure to the loading 
solution. The cells were recovered in the glycine bath for 30 minutes then the live cells 
were imaged. 
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Glutamate  
Three different glutamate (Sigma) concentrations were utilized throughout the main 
experiments namely: 250, 500 and 750nM. These are the final concentrations after the 20X 
dilution factor on addition of 25 µl of the stimulus to the well containing 475µl Locke’s 
solution. These glutamate aliquots are made fresh for each experiment by dissolving in 
Locke’s solution. Other concentrations used in experimentation were 1µM, 10µM and 
100µM. 
Ionomycin 
Determining the essential function of Ca2+ in controlling numerous cellular pathways has 
been significantly aided by Ca2+ ionophores such as Ionomycin. Ionomycin is an antibiotic 
that serves as a relatively specific calcium ionophore (Figure 3-2) (66,67). This compound 
perforates the cell membrane to facilitate rapid calcium influx across the cell membrane 
into the cytosol, maximizing the fluorescence calcium intensity. Ionomycin was frozen in 
a -80◦C freezer in aliquots solubilized in dimethyl sulfoxide (DMSO) at a stock 
concentration of 665µM until it was ready to be used during experimentation, in which the 
stock concentration is then mixed with Locke’s solution to obtain a working concentration.  
DMSO is a commercial solvent that is sometimes used to preserve organs and other tissues. 
The structure of ionomycin is shown in Figure 3-2. 
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Figure 3-2: Structure of Ionomycin (68) 
 
Potassium Chloride. (KCl, Sigma). KCl is known to produce a transient increase in calcium 
influx. The KCl solution is dissolved in Locke’s solution to obtain a desired working 
concentration of 50mM. When testing the calcium imaging system, it is often useful to use 
stimuli like high concentrations of KCl or Ionomycin that are known to cause an increase 
in the intracellular calcium concentration and calcium free extracellular solutions such as 
EGTA, BAPTA or bicuculline that will reduce the calcium concentration. 
3.2.2 Measuring and Analyzing Calcium Fluorescence Intensity 
After the experiments were done, InCyt Basic Im™ Imaging System software was used to 
create regions of interest (ROIs) around every neuron that responded dynamically to 
glutamate by calcium influx (illustrated by fluorescence increase). In the experiments done 
with mixed neuronal cultures, the neurons are the main cells that respond to the 
subthreshold glu concentrations. GFAP staining was done to estimate the glial depletion 
category for each experiment. The morphology of the cells was also used to determine the 
glial depletion category of each cell culture.  Astrocytes require higher glu concentrations 
to cause calcium influx and the calcium response tends to be slower and more sustained 
than in neurons. The ROIs were then used to measure fluorescence intensity over time in 
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the specified area. The ROIs were then normalized to their starting values for correlation 
between the cells within the experiment and other experiments. The data is then represented 
using line tracings and the average is then calculated by averaging all ROIs for triplicate 
experiments. An example of the line tracings derived from an experiment is shown in 
Figure 3-3. 
 
Figure 3-3: One example of the line tracings derived from a calcium imaging experiment 
 
Under normal resting conditions, the cytosolic calcium concentration is in the 
nanomolar region, when the cells are stimulated, this concentration can reach micromolar 
amounts. Extracellular glutamate concentrations are in micromolar quantities around the 
synapse and millimolar quantities in the synaptic and intracellular vesicles. Research has 
shown that exogenous concentrations of L-glutamate greater than one micromolar have an 
electro-desensitizing effect on the NMDA receptor (69,70). 
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The calcium imaging experiments done in this project will test for calcium 
signalling in the presence of glu concentrations less than one micromolar to prevent NMDA 
desensitization and excitotoxicity. This will be done to ensure that glial density is the main 
contributor to changes in signal processing as this will be the only variable changed. To 
determine the effect that changes in glial density have on the calcium signalling capacity 
of neuronal cells, normal (glia rich) primary cortical cell micro-environments must be 
tested to obtain a control of calcium signalling under healthy conditions. These healthy 
(undisturbed) cortical cultures can maintain calcium influx due to glu stimulation by the 
action of specific homeostatic mechanisms (mentioned in Chapter One). It is important to 
note that the spikes shown in the data set are caused exclusively by neurons because higher 
(millimolar) concentration of glutamate are needed to induce calcium spiking in glial cells. 
Figure 3-4 displays glutamate induced calcium fluorescence in undisturbed (control) 
cortical cultures stimulated by increasing submaximal glu concentrations 250, 500, 750 
nM. 
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Figure 3-4: Line tracings of primary neuronal cortical cultures high in glia response to 
additions of 250nM, 500nM and 750nM glu additions. Top Panel: Each line represents 
individual cells (ROIs). Bottom Panel: Average of all ROIs 
 
 
Each colored line represents a single neuron’s response to glutamate stimulation 
and was chosen randomly. The average of the neuronal population is depicted by the blue 
line in the graph at the bottom. Each spike illustrates the initial baseline readings followed 
by a rise in intracellular calcium concentration followed by a return to baseline levels. It is 
possible that intracellular calcium levels can be elevated by release from intracellular 
stores, however this is a slower, more sustained process, this is not the case in these 
experiments as the spikes take place within seconds. Biochemical calcium responses are 
slower than electrical responses and require multiple seconds to produce a spike. The 
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length of time that the cell takes to recover from stimulation is dependent on the negative 
feedback mechanism provided by the glu re-uptake functionality of astrocytes.    
Once the control is established, the effect of glial density on calcium signalling is 
then studied. This is done by performing identical experiments to the distinct micro-
environments discussed in chapter two. The results of these experiments are shown in 
Figures 3-5 to  3-14.  
 
 
Figure 3-5: Line tracings of primary neuronal cortical cultures with mildly depleted glia 
response to additions of 250nM, 500nM and 750nM glu. Top Panel: Each line represents 
individual cells (ROIs). Bottom Panel: Average of all ROIs. 
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The individual ROIs in Figure 3-6 represent typical calcium signaling which should 
be observed in cultures with partially depleted glia. The average depicts how glia uptake 
the exogenous glutamate with decreasing calcium influx after each stimulation. 
 
 
Figure 3-6: Line tracings of primary neuronal cortical cultures with partially depleted 
glia response to additions of 250nM, 500nM and 750nM glu. Top Panel: Each line 
represents individual cells (ROIs). Bottom Panel: Average of all ROIs 
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When exposed to glutamate, the cultures severely depleted of glia display very broad and 
high amplitude response to calcium influx, see Figure 3-7. 
 
 
 
Figure 3-7: Line tracings of primary neuronal cortical cultures with severely depleted 
glia response to additions of 250nM, 500nM and 750nM glu. Top Panel: Each line 
represents individual cells (ROIs). Bottom Panel: Average of all ROIs. 
 
 
 
These broad peaks are also indicators of excitotoxicity; line tracings of excitotoxic 
responses plateau, meaning the tracing does not return to baseline. The excitotoxic 
response in calcium signaling to glutamate could infer spillover of glutamate onto the 
dendritic NMDA receptors. 
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Mixed glial cultures containing astrocytes and microglia require higher 
concentrations of glu to elicit fluorescence calcium responses. When exposed to glutamate, 
the mixed glial cultures display narrow peaks with high amplitude response to calcium 
influx, see Figure 3-8. 
 
 
Figure 3-8: Line tracings of primary mixed glial cortical cultures responses to additions 
of 100µM glu. Top Panel: Each line represents individual cells (ROIs). Bottom Panel: 
Average of all ROIs 
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When exposed to glutamate, the mildly depleted mixed glial cultures also displayed 
narrow peaks with high amplitude response to calcium influx, see Figure 3-9. 
 
 
 
Figure 3-9: Line tracings of mildly depleted primary mixed glial cortical cultures 
responding to additions of 100µM glu. Top Panel: Each line represents individual cells 
(ROIs). Bottom Panel: Average of all ROIs 
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The partially depleted cultures behaved similarly to the mixed and mildly depleted 
cultures in displaying narrow peaks with high amplitude response to calcium influx (Figure 
3-10). 
 
 
 
Figure 3-10: Line tracings of partially depleted primary mixed glia cortical cultures 
responding to an addition of 100µM glu. Top Panel: Each line represents individual cells 
(ROIs). Bottom Panel: Average of all ROIs 
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The severely depleted cultures responded to glu stimulation with high amplitude 
response to calcium influx without returning to baseline levels as seen in excitotoxic micro-
environments (Figure 3-11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11: Line tracings of severely depleted primary mixed glia cortical cultures 
responding to an addition of 100µM glu. Top Panel: Each line represents individual cells 
(ROIs). Bottom Panel: Average of all ROIs 
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Astrocytes also require high concentrations of glu to elicit fluorescence calcium 
responses, and the calcium response tends to slowly increase with time. The pure astrocyte 
cultures also tend to respond with broader peaks as expected. The brain functions optimally 
in with functioning microenvironments containing neurons and glial cells. Although pure 
astrocyte cultures look completely healthy under the microscope, we have observed that 
these cells take longer to recover from glu stimulations that mixed cultures (Figure 3-12). 
 
Figure 3-12: Line tracings of pure astrocyte cortical cultures responding to an addition of 
100µM glu. Top Panel: Each line represents individual cells (ROIs). Bottom Panel: 
Average of all ROIs 
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When exposed to glutamate, the mildly depleted pure astrocyte cultures respond 
with broad, high amplitude peaks indicating very high calcium influx (Figure 3-13). 
Figure 3-13: Line tracings of mildly depleted primary pure cortical astrocyte cultures 
response to additions of 100µM glu concentrations. Top Panel: Each line represents 
individual cells (ROIs). Bottom Panel: Average of all ROIs 
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When exposed to glutamate, the partially depleted pure astrocyte cultures respond 
with broader, high amplitude peaks indicating an even higher calcium influx than the 
mildly depleted cultures (Figure 3-14). 
 
Figure 3-14: Line tracings of partially depleted primary pure cortical astrocyte cultures 
response to additions of 100µM glu concentrations. Top Panel: Each line represents 
individual cells (ROIs). Bottom Panel: Average of all ROIs 
 
 
 
 
Like the severely depleted mixed glial cultures, the severely depleted pure astrocyte 
cultures responded to glu stimulation with a high amplitude response to calcium influx 
without returning to baseline levels as seen in excitotoxic micro-environments (Figure 3-
15). 
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Figure 3-15: Line tracings of severely depleted primary cortical pure astrocyte cultures 
response to additions of 100µM glu concentrations. Top Panel: Each line represents 
individual cells (ROIs). Bottom Panel: Average of all ROIs 
 
 
 
In summary, the different conditions resulted in the following findings. The mildly 
and partially glia depleted cultures behaved similarly to glia rich cultures with narrow 
width responses (peaks) to calcium influx. It is important to note that the although the range 
for partially glia depleted cultures was between thirty and sixty percent depleted, the 
cultures used in these experiments were between thirty-five and forty-five percent depleted. 
The severely depleted cultures using both FdU and AraC displayed very broad and high 
amplitude responses to glu stimulation. The broad peaks are indicative of excitotoxicity; 
line tracings of excitotoxic responses do not return to baseline. The excitotoxic response in 
calcium signaling to glutamate may be caused by glutamate also binding to the dendritic 
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NMDA receptors after over-exposure due to the altered negative feedback component (glia 
density). 
3.3 Image Analysis 
This work is a continuation of Dr. Kinsey Kelly’s dissertation research (45). In her 
studies, she concluded that the area under the curve was the best predictor of neuronal 
response to glutamate stimulation. We have therefore continued using the area under the 
curve (AUC) as the defining characteristic indicating the strength of the signal induced by 
glutamate stimulation. This parameter is essential for determining calcium information 
processing and will be used throughout the upcoming chapter. The final parameter used in 
this analysis was the number of cells responding to a stimulus. This will be used to 
determine the level of synchrony within the culture. 
3.3.1 Area Under the Curve 
The trapezoidal rule was used to determine the AUC for the fluorescence intensity curve, 
f. The trapezoidal equation used is as follows: 
∫ 𝑓(𝑥)𝑑𝑥 ≈ (𝑏 − 𝑎)
𝑓(𝑎) + 𝑓(𝑏)
2
𝑏
𝑎
 
Where time (s) is a and b, and their corresponding fluorescence intensities are f(a) and f(b) 
at the time interval’s end points. An average of evaluated areas is then compiled for every 
ROI. To improve analysis, we developed a MATLAB code to measure area under the curve 
using trapezoidal Riemann sums. The MATLAB code and instructions for using the code 
are found in Appendix C.  
AUC elucidates the effects of altered glial cell density on calcium signaling when 
trying to determine the amount of calcium which has permeated into the cytosol. As 
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expected, severely depleted glial cultures have increased AUC as glu concentrations 
increase. In contrast, partially and mildly depleted glial cultures have very low AUC per 
treatment and a slight decrease in AUC with increasing treatment additions (not statistically 
significant). In mixed neuronal cultures, the AUC for the calcium response curves at 
baseline and after treatment with 250, 500 and 750 nM glu for the control (untreated) are 
51, 385, 230, and 412 respectively, with standard deviations of 27.38, 12.32, 15.92, and 
57.12 respectively. The AUC for the calcium response curves at baseline and after 
treatment with 250, 500 and 750 nM glu for the mildly depleted cultures are 58, 258, 240, 
and 367 respectively, with standard deviations of 23.45, 20.154, 36.12, and 45.23 
respectively. The AUC for the calcium response curves at baseline and after treatment with 
250, 500 and 750 nM glu for the partially depleted cultures are 40, 358, 400, and 425 
respectively, with standard deviations of 11.36, 28.56, 21.33, and 36.21 respectively.  
These results are shown in Figures 3-16 to 3-19.  
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Figure 3-16:  Area under the curve (AUC) in response to glutamate treatments to mixed 
neuronal cultures high in glia (control), mildly glia depleted (MD) and partially depleted 
(PD). Error bars = sd, n=18. 
 
 
 
 
 
The area under the curve in mixed neuronal cultures severely depleted of glia was at least 
ten times greater than the other conditions. The AUC for the calcium response curves at 
baseline and after treatment with 250, 500 and 750 nM glu for the severely depleted 
cultures are 20, 2374, 6125, and 8236 respectively, with standard deviations of 2.36, 
112.47, 231.885, and 212.36 respectively. This indicates that the severely depleted 
microenvironments recover from subthreshold (physiological) glutamate concentrations at 
a much lower rate than the other two conditions (Figure 3-17).  
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Figure 3-17:  Area under the curve (AUC) in response to glutamate treatments to mixed 
neuronal cultures severely glia depleted (SD). Error bars = sd, n=18. 
 
 
In mixed glial cultures, the AUC for the calcium response curves at baseline and 
after treatment with 100µM glu for the control (untreated) are 17, and 321 respectively, 
with standard deviations of 5.5, and 72.112 respectively. The AUC for the calcium 
response curves at baseline and after treatment with 100µM glu for the mildly depleted 
cultures are 13 and 397 respectively, with standard deviations of 3.47 and 63.24 
respectively. The AUC for the calcium response curves at baseline and after treatment with 
100µM glu for the partially depleted cultures are 5 and 356 respectively, with standard 
deviations of 1.21, and 54.21 respectively. The AUC could not be measured in severely 
depleted cultures as the fluorescence values remained elevated.  There were no statistical 
differences in AUC of mixed glial cultures in each microenvironment (Figure 3-18).  
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Figure 3-18:  Area under the curve (AUC) in response to glutamate treatments to mixed 
glial cultures high in astrocyte (control), mildly depleted (MD) and partially depleted 
(PD). Error bars = sd, n = 18. 
 
 
In pure astrocyte, the AUC for the calcium response curves at baseline and after 
treatment with 100µM glu for the control (untreated) are 15, and 852 respectively, with 
standard deviations of 5.5, and 57.8 respectively. The AUC for the calcium response curves 
at baseline and after treatment with 100µM glu for the mildly depleted cultures are 13 and 
1200 respectively, with standard deviations of 4.63, and 355.37 respectively. The AUC for 
the calcium response curves at baseline and after treatment with 100µM glu for the partially 
depleted cultures are 7 and 2020 respectively, with standard deviations of 2.11, and 334.17 
respectively. Like the mixed glial cultures, there was also no statistical difference observed 
in the AUC of the pure astrocyte cultures in each microenvironment (Figure 3-19). The 
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AUC could not be measured in severely depleted cultures as the fluorescence values 
remained elevated. 
 
 
Figure 3-19:  Area under the curve (AUC) in response to glutamate treatments to pure 
astrocyte cultures high in astrocyte (control), mildly depleted (MD) and partially depleted 
(PD). Error bars = sd, n=18. 
 
 
Calcium imaging was used to visualize and analyze calcium influx due to cellular 
exposure to exogenous glu. In these experiments, the cells are stimulated by different glu 
concentrations and the calcium influx is detected by calcium indicators loaded in the 
cytosol. Calcium response curves are then developed by imaging software measuring 
changes in fluorescence (when the indicator is bound to calcium). These experiments were 
done in mixed neuronal, mixed glial and pure astrocyte cultures. Subthreshold 
(physiological) concentrations of 250, 500 and 750 nM glu were used to stimulate the 
mixed neuronal cultures and 100µM glu was used to stimulate the mixed glial and pure 
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astrocyte cultures. The results indicate that severely depleted cultures recover at a much 
slower rate than any other condition and our hypothesis that decreasing the glial cell density 
will increase the amount of glutamate to which the neurons are exposed was supported.  
To further study the calcium dynamics, this project is also geared towards the 
development of mathematical tools to model each phase in the calcium response curve 
which is discussed in chapter four.   
 
. 
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CHAPTER 4 
 
MATHEMATICAL TOOLS  
 
4.1 Introduction 
The third goal for this project is to develop mathematical tools for studying brain 
cell dynamics. Given the recent mathematical advancements in neuroscience, new ways of 
studying one of the most complicated organs in the body (the brain) have been developed. 
Our understanding of neuronal communication in the processes involved in development, 
maintenance, and disorders of the nervous systems has been significantly improved.  
Neurons communicate via electro-chemical signalling.  One of the most prominent 
examples of neuronal communication is neurotransmission.  Electrical stimulation of the 
presynaptic neuron causes the release of glutamate which then binds to the NMDA receptor 
on the post synaptic membrane which may either be at slightly depolarized or resting 
membrane voltages. The channel then opens and allows positively charged ions such as 
Na+ and Ca2+ into the cells. This influx of positive charge causes an increase in membrane 
potential which, if sufficiently high, will cause the cell to fire an action potential which is 
seen as a spike if the membrane potential is being measured. This in turn causes the release 
of glutamate from the axon terminal and the signal travels within the neuronal circuit. In a 
healthy brain, synchronization within and between neural micro-circuits is an important 
mechanism for neural signalling and information processing(72).  
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A growing number of tools have been developed allowing the simulation of spiking 
neuronal networks. Increasing evidence suggests that an improved understanding of the 
synchronization process would be achieved by studying the bidirectional signalling 
between astrocytes and neurons. Astrocytes are connected via gap junctions and form a 
large functional synctium within neuronal networks. Although astrocytes cannot fire action 
potentials, they respond to neuronal activity by an increased intracellular calcium 
concentration.  These astrocytic responses to neuronal signalling introduces the concept of 
the tripartite synapse, where the astrocyte (third element) monitors and responds to synaptic 
activity. In this chapter, a dynamic, functional model of neurons and astrocytes within the 
neural circuit and the effect that astrocyte density has on neural synchrony will be 
discussed. 
4.2 Modeling each phase after glutamate stimulation 
The goal of this chapter is to describe some of the mathematical tools that have 
been developed to study neuronal interactions. In addition to developing a model to show 
the effect of astrocytes on neural synchrony, we have been able to use mathematical 
equations to model the distinct phases in the calcium response curve when brain cells are 
stimulated with glutamate. When graphed, the cellular response to glutamate can be 
considered in three sections: the cells’ natural state which is characterized by small baseline 
oscillations; the immediate response to the stimulus which results in a sharp upward peak, 
and the recovery of the cells from the stimulus seen as a decrease in fluorescence. In Figure 
4-1, a discrete logistic equation is used to model the random oscillatory behavior of cells 
before any stimulation takes place. Discrete logistic equation: 
𝑥𝑡+1 = 3.7𝑋𝑡(1 − 𝑋𝑡) + 0.3 Eqn. 4-1 
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Figure 4-1: Plots of (a) averaged baseline response, (b) baseline response modeled by 
xt+1=3.7xt(1-xt) +0.3. For all equations, xt is the fluorescence at any given time, t, and ti is 
the time since the introduction of the stimulus. 
 
 
 
This equation is a pseudo-random generation of numbers; each number being 
determined by the previous value. Xt is the fluorescence at any given time t. Ti is the time 
since the introduction of the stimulus.  
The second part of the response curve is the increase in fluorescence due to 
glutamate stimulation. The equation of a straight line (𝑦 = 𝑚𝑥 + 𝑏)where m is the slope 
of the line and b is the y intercept, is used to model this part and the results are shown in 
Figure 4-2.  
 
77 
 
 
Figure 4-2: Plots (a) averaged immediate response to the glutamate, (b) response to  
glutamate modeled by xt=13ti-12. For all equations, xt is the fluorescence at any given 
time, t, and ti is the time since the introduction of the stimulus. 
 
 
 
The third and final part of the response curve is the recovery period characterized by a 
rapid decrease in fluorescence which we have used the exponential decay equation to 
model. This is shown in Figure 4-3 
 
. 
 
 
 
 
 
Figure 4-3: Plots (a) averaged fluorescence during the recovery period, and (b) recovery 
period modeled by xt=14e
-0.14ti+1. For all equations, xt is the fluorescence at any given time, 
t, and ti is the time since the introduction of the stimulus. 
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The actual baseline oscillations in mixed neuronal cultures that are more dynamic and 
chaotic than astrocyte cultures are shown in Figure 4-4.  
 
 
Figure 4-4: Baseline oscillation recorded in mixed neuronal cultures 
 
After running the discrete logistic equation (Eqn. 4-1) 160 times the following graph is 
obtained (Figure 4-5). 
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Ionomycin is added to brain cell cultures to obtain a sustained fluorescence maximum. 
One equation that can be used to describe this phenomenon is: 
𝑓(𝑡) = 𝑎(1 − 𝑒−𝑏(𝑡−𝑡0)) + 𝑏 Eqn. 4-2 
Where a, b and c are curve fit parameters, 𝑡 is any given time and 𝑡0 is the time since the 
introduction of the stimulus.  Figure 4-6 shows the type of wave form derived when Eqn. 
4-2 is plotted. 
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Figure 4-6: Graph showing waveform derived from Eqn. 4-2  
During a calcium imaging experiment, the rising slope of the signal is typically different 
from the falling slope (calcium influx occurs more rapidly than efflux). One model for all 
three stages of the curve collectively is the Landau function: 
𝑓(𝑡) =  
𝑎
2𝜋
𝑒−𝑏(𝑡+𝑒
𝑐𝑡) + 𝑑 Eqn. 4-3 
Where a, b, c, and d are curve fit parameters. Figure 4-7 shows the type of wave form 
derived from this equation.  
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Figure 4-7:  Graph showing wave- form derived from Eqn. 4-50. 
 
In addition to the segmented analysis, some more mathematical modelling tools can be 
found in Appendix C. 
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CHAPTER 5 
 
CELLULAR INTERACTION WITH NOVEL BIOMATERIALS 
5.1 Introduction 
The brain is arguably one of the most important organs of the body and as such, the 
human body has developed many intrinsic protective mechanisms. Unfortunately, the brain 
can be negatively affected by many conditions such as stroke, hypoxia, neurodegenerative 
diseases, cancer, and acute trauma which causes a loss of neuronal populations and 
neurological symptoms ensue. Presently, most treatment options modify disease symptoms 
but are not able to restore the lost neuronal populations or stop neurodegenerative 
processes.     
Biomaterials demonstrate great promise for use as tools in a wide range of 
biomedical applications.  For applications in neuroscience, these materials have been used 
to enable and augment targeted delivery therapeutic agents such as drug or proteins to the 
brain (82). Biomaterial scaffolds can be used as bridges, cell carriers, and targeted drug 
delivery vehicles, for transporting regenerative and therapeutic agents to damaged neuronal 
circuits.  With the advancements in nanotechnology and material science, scientists are 
confident in the possibility of developing treatments for damage that is confined to 
localized neuronal populations or neural circuits. This has stimulated the search and 
development of drug delivery systems and tissue engineering approaches of neuronal 
damage repair (82).  
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Highly specific interactions with neural networks can be accomplished using 
nanomaterials (83). Nanotechnology based clinical tools are in their preliminary stages of 
development because of the complexity of neural networks and the central nervous system 
at large. Nanotechnology is the study of materials and/or devices with the smallest 
functional dimension on the nanometer scale (~1-100nm). There are two key applications 
for nanomaterials in neuroscience: platform nanotechnologies and tailored 
nanotechnologies (83).  Platform nanotechnologies serve as building blocks for addressing 
neuroscience questions and tailored nanotechnologies are designed to complete materials 
used in treating neurological diseases.   
5.2 Biomaterials Used in Neuroscience 
Neurological disorders such as traumatic brain injuries, stroke, and epilepsy result 
in neuronal loss and disruption of the brain parenchyma. Current treatment strategies are 
limited in that they can only mitigate the degeneration process or alleviate the symptoms 
but do not reverse the condition. In contrast, regenerative cell-based therapies offer long-
term hope for many patients. Bioactive scaffolds are likely to reinforce the success of cell 
replacement therapies by providing a microenvironment that facilitates the survival, 
proliferation, differentiation, and connectivity of transplanted and/or endogenous cells.  
5.2.1 Quantum Dots 
Quantum dots (QD) are nanocrystalline structures made of semiconductor 
material typically consisting of about 10-50 atoms (84). A remarkable feature of quantum 
dots is the size dependence of their emission wavelength. The electrons and electron holes 
within the semiconducting material are confined within the region of the crystalline 
structure. Due to this confinement, the electrons and the electron holes can be modeled 
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quantum mechanically as particles confined by an infinite potential of diameter equal to 
the size of the crystal (85). Another important feature of quantum dots is their narrow 
emission and broad absorption spectra allowing multiplexing of different colored 
quantum dots. This feature implies that multiple colors of quantum dots may be used with 
a single excitation source. A quantum dot usually consists of a core semiconducting 
material (heavy metal) surrounded by an intermediate unreacttive   shell typically made 
of zinc sulfide, which not only protects the crystalline structure of the core but can also 
boost the quantum yield. The outer coating can be made of bioactive molecules such as 
antibodies tailored to specific functions (Figure 5-1). 
 
 
   
 
 
 
 
 
 
 
 
 
Figure 5-1: Diagram showing structure of semiconductor fluorescent quantum dot 
nanocrystal (86) 
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 Due to their nanoparticle size, quantum dots are emerging as a powerful tool to 
track living cells in vitro and in vivo. They can also be functionalized with biomolecules, 
allowing for specific targeting of cells, which may aid in development of more accurate 
biological models. 
These properties make quantum dots potentially new tools in neuroscience and 
neuroscience specific tools are being developed. These nanoparticles are particularly suited 
for studying neurons and glia as they can be used to visualize, measure, and track specific 
molecular events over longer periods of time than traditional imaging techniques with 
minimal photo bleaching.  Because of their relatively small size, they can be used to track 
intra and intercellular events that otherwise evades larger imaging molecules (86).  
Recently, many neuroscience specific tools are being developed. Vu et al. used β Nerve 
Growth Factor (βNGF) functionalized quantum dots to promote neurite outgrowth in 
pheochromocytoma 12 (PC12) cells (87).  Quantum dots can be used to track and visualize 
functional responses in neurons, but this new material is highly toxic therefore are not used 
if an alternative exists. 
5.3 Copper Homeostasis in the CNS 
Copper (Cu) is an essential trace element involved in red blood cell development, 
collagen formation, maintenance of both immune and nerve cells. Cu also functions as a 
cofactor in a number of enzyme dependent metabolic reactions (88). During infection, Cu 
facilitates the production of interleukin-2 by activated lymphocytic cells (89). Tiny 
amounts of copper are needed for healthy brain development and synthesis of 
neurotransmitters essential for neural signal transduction. Due to its reactivity, the 
presence of copper within a system can facilitate the development of reactive oxygen 
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species in a Fenton-like reaction causing cell death and oxidative stress. This is especially 
deleterious to organs to the brain as neurons are post-mitotic cells and become terminally 
differentiated early in development thus making it almost impossible to replace dead 
cells(90). As a result, copper metabolism within the body must be tightly regulated to 
supply sufficient Cu to target areas but also to prevent Cu induced oxidative stress (91).  
Cu deficiency and over expression can severely diminish brain function. Certain 
neurodegenerative diseases are associated with impaired Cu homeostatic mechanism such 
as Menkes disease, Wilson’s disease, and Alzheimer’s disease (91). 
 The presence of several copper-containing enzymes in astrocytes suggests that 
astrocytes are crucial in regulating Cu metabolism in the brain. Their location (between 
neuronal elements and capillary endothelial cells) gives them the ability to transport Cu 
from the blood brain barrier to the parenchymal brain cells (92). Astrocytes store and export 
Cu efficiently to the neurons and although the mechanism is not fully understood, there is 
evidence suggesting that in the normal brain, Cu uptake is facilitated by the copper 
transporter receptor 1(Ctr1) and other presently unidentified transporters. Thus far, the 
accepted KM value for copper uptake is 10µM and the expression of Ctrl1 on astrocytes 
exposed to copper suggests that this receptor is responsible for high affinity copper uptake 
(93) (Figure 5-2) 
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Figure 5-2: Diagram showing summary of copper uptake in astrocytes (93) 
 
Ctrl1 receptors and other Ctrl1 independent mechanisms are responsible for the 
uptake of Cu in astrocytes. Some of these mechanisms include the divalent metal transport 
1 (DMT1) or the members of the ZIP family of metal transporters(93). Cu is then 
transported to various cellular regions via copper chaperones (CCS) to superoxide 
dismutase 1 (SOD1) or Cox17 to Sco1/2or Cox11 for subsequent incorporation into 
cytochrome c oxidase and by antioxidant protein 1 (Atox1) to ATP7A. ATP7A then 
transports copper into the trans-Golgi network to be incorporated into copper-dependent 
enzymes. When the cellular copper level rises above a certain threshold, ATP7A 
translocates reversibly via vesicles to the plasma membrane to export copper.  
Exposure of astrocytes in culture to excess Cu causes the cellular glutathione 
(GSH) levels to increase and initiates metallothionein synthesis(93). This suggests that 
excess Cu is stored in the form of GSH and metallothioneins in astrocytes. This stored 
Cu is then released via ATP7A to supply the neurons (Figure 5-3).  
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Figure 5-3: Diagram of proposed model of astrocytic copper supply to neurons (93) 
 
Astrocytes can be considered as a therapeutic target for disturbances in brain copper 
homeostasis as they are able to efficiently uptake, store, and export copper   
5.3.1 Copper containing High Aspect Ratio Structures 
Our lab has recently developed a copper containing high-aspect ratio structure 
(CuHARS) synthesized in an aqueous solution with sizes ranging from nano- to the micro- 
meter as confirmed by electron microscopy.  We have discovered that over time, and under 
biological conditions typically used in cell culturing, these structures are formed. CuHARS 
are made up of a copper metal component (40%) and the amino acid dimer cystine as the 
organic component (60%) as indicated by the thermo-gravimetric analysis in (results not 
shown) and by scanning electron microscopy (SEM) (94). These structures, once 
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generated, are stable without agglomeration, for months-years under refrigeration when 
stored in water.  
5.3.2 Biocompatibility of CuHARS 
Many biomedical applications utilizing different biomaterials such as drug delivery 
would require substantial amounts of the material to be administered to the cells or brain 
region of interest. As a result, it is important that the cytotoxic effect of moderate to high 
concentrations of these materials is being investigated. The discovery of this material has 
opened the possibility of creating functionalized biomaterials with growth factors (for 
neuronal recovery and regeneration) or antibodies for targeted delivery in the brain. 
Interactions between the HARS and different cell types have been studied and as a result, 
we are interested in evaluating the biocompatibility of this material. In this study, we 
investigated the cytotoxic effects of the CuHARS material on PC12 cells as a model for 
neuronal development. One property of PC12 cells is their quantifiable, rapid, and 
reversible response to nerve growth factor (NGF). On exposure to NGF, PC12 cells 
develop neurite-like extensions up to 1cm in length(95) . We examine and quantify the 
specific effects that our HARS biocomposite have on cultured PC12 cells and study their 
ability to respond to the biological cue NGF as compared with control cells. The main 
objective of this study was to examine the cytotoxicological effects of our previously 
developed copper containing biocomposite which is intended for use in neurological cell 
culture systems.    
The protocols used for synthesizing the CuHARS, cell culture and studying the 
cytotoxic effects of the materials on cells are outlines in APPENDIX A. In these studies, 
this method was used to evaluate the potential adverse effects of the biocomposite material 
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in PC12 cells. The assay was done after exposure for 6, 12, 24 and 48 hours. Exposure to 
increasing concentrations of CuHARS biocomposite resulted in a dose-dependent 
diminishing viability of PC12 cells using MTT method. At very low to moderate 
concentrations, cell viability was not significantly affected, however at a concentration of 
50μg/ml cell viability significantly decreased. The metabolic activity of PC12 cells 
decreased in a concentration dependent manner (Figure 5-4). 
 
 
Figure 5-4: Effect of varying CuHARS concentration on mitochondrial toxicity of PC12 
cells A) Copper Nanoparticle (CuNP) treatment. B) CuHARS treatment. Y: Axis 
values=Relative Absorbance normalized to the controls (no treatment). 
 
 
As mentioned previously, astrocytes are a viable target for treatment with copper. 
The first step in using any biomaterial as a therapeutic agent is to study the biocompatibility 
of the material within the target environment which in this case is the brain. The cytotoxic 
activity of CuHARS was tested with primary astrocytes derived from Sprague –Dawley 
newborn rat pups (age ≤ 48hours). It was found that the metabolic activity of the primary 
astrocytes also decreased in a concentration dependent manner 
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5.3.3 Functionalization of CuHARS using Layer by Layer Assembly 
Drug delivery systems are developed for targeted delivery and controlled release of 
drugs. Our lab is interested in using the self-assembled biohybrid CuHARS material as a 
drug delivery vehicle, as it is a biocompatible material which is fully degraded overtime in 
cellular media (96).  The main goal of this section is to describe the functionalization of 
the CuHARS with ionomycin. The CuHARS are negatively charged materials. In using the 
Layer by Layer method, the CuHARS can be functionalized by adding alternating layers 
of oppositely charged materials with washing steps between. We used a polycationic 
(positively charged) material called poly-lysine to coat the CuHARS materials then we 
would like to attempt to add another layer of the ionophore A21387 to the PLL labelled 
material. The protocol utilized for this process can be found in Appendix A. To confirm 
that the CuHARS were successfully coated with PLL we used microscopy to observe the 
reverse coffee ring effect in the coated material. When a drop of liquid containing 
particulates dries on a solid surface, suspended particulate matter is deposited in a ring-like 
fashion which is known as the coffee ring effect (102). The CuHARS material, because it 
does not form particulates does not exhibit this effect. The unlabeled CuHARS are more 
evenly distributed throughout the well. We observed that the PLL labelled CuHARS were 
generally found at the edge of the well more than the uncoated CuHARS. Figure 5-5 is a 
schematic of the observed distribution of CuHARS throughout the entire well and Figure 
5-6 are Bright-  
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Figure 5-5: Schematic illustrating distribution of CuHARS throughout individual wells 
in the 48 well cell culture treated plate. Left) PLL coated CuHARS, Right) Uncoated 
CuHARS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-6: Images showing PLL coated and uncoated CuHARS association with edge of 
the well in a 48 well cell culture treated well. Left) (Top and bottom) Uncoated 
CuHARS, Right) (Top and bottom) PLL coated CuHARS. White arrows = edge of the 
droplet. Scale Bars = 100µm 
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 Once the droplet has fully dried images of the middle of the droplet were taken. We 
found that the coated CuHARS were less dense in the images that the uncoated CuHARS. 
The uncoated CuHARS are more motile than the coated CuHARS. They are also more 
evenly dispersed throughout the droplet, therefore when they dry more uncoated CuHARS 
are found in the middle of the dried droplet. Results are shown in Figure 5-7. 
 
 
 
Figure 5-6: Images showing dried PLL coated and uncoated CuHARS association with 
middle of the well in a 48 well cell culture treated well. Bottom Panel: Uncoated 
CuHARS, Top Panel: PLL coated CuHARS. Scale Bars = 100µm 
 
  
Image analysis software such as Image J and Image ProPlus can be used to find the 
number of object within a field after defining what an object is. This can be used to quantify 
the CuHARS association with cells, middle of droplet. The average distance of CuHARS 
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to the edge of the droplet can be used to quantify the CuHARS association with the droplet 
edge. 
The antibiotic ionophore A23187 is an ionophorous antibiotic that reduces 
membrane permeability barriers to biologically important alkali cations such as calcium. 
Figure 5-8 shows the structure of A23187. 
 
 
Figure 5-8: Diagram showing the structure of A23187 at the free acid. The two 
structures are in “open and closed” conformation, respectively (top to bottom) (101) 
  
 
To confirm that this process is successful, several methods will be utilized. We have 
observed that uncoated CuHARS are very motile in water under the microscope. This is 
believed to be due to the electrostatic forces repelling the materials as they are negatively 
charged. After coating the CuHARS with Poly-L-lysine, which is a positively charged 
polymer, it is expected that the material will become less motile in a cell culture treated 
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plate. This was observed under the microscope and movies of the material movement were 
recorded (results not shown). We also observed how the PLL coated CuHARS interacted 
with cells. It was expected that the coated materials would be more readily associated with 
cells as positively charged particles exert attractive forces on the negatively charged cell 
membrane. The cells were plated at two densities of 10,000 and 20,000 cells per well and 
two concentrations of CuHARS added. The cells were imaged three hours after the material 
was added and overall, the PLL coated CuHARS were more readily associated with the 
cell. Figures 5-9 and 5-10 illustrate the association of PLL coated versus uncoated 
CuHARS to CRL 2303 cells. 
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Figure 5-9: Images illustrating Uncoated CuHARS and their association with CRL 2303 
cells. Left (Top and bottom) Bright Field images highlighting CuHARS; Right (Top and 
Bottom) Phase contrast images of the same area of highlighting cells. Scale Bars = 
100µm. White Arrows = CuHARS 
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Figure 5-10: Images illustrating PLL-coated CuHARS and their association with CRL 
2303 cells. Left (Top and bottom) Bright Field images highlighting CuHARS; Right (Top 
and Bottom) Phase contrast images of the same area of highlighting cells. Scale Bars = 
100µm. White Arrows = CuHARS 
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Figure 5-11: Zoomed in Phase image of uncoated CuHARS and their association with 
CRL 2303 cells. Scale Bars = 100µm. White Arrows = CuHARS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
Figure 5-12: Zoomed in Phase image of PLL-coated CuHARS and their association with 
CRL 2303 cells. Scale Bars = 100µm. Yellow Arrows = CuHARS 
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE WORK 
 
6.1 Conclusions 
An emerging viewpoint in which glia are contributors to calcium processing in the 
brain has been elucidated by engineering normal cultures and subjecting the cultures to 
submaximal glutamate stimuli. Tissue engineered microenvironments were constructed 
to test the effects of the glial cell density have on calcium information processing. 
Neuronal cultures severely depleted (greater than sixty percent depletion) of glia 
responded to increasing glutamate additions with large, slightly unsynchronized 
responses with the greatest area under the curve (AUC) observed which returned to 
baseline the slowest of the three micro-environments developed. Cultures partially 
depleted (thirty to sixty percent depletion) of glia, responded to increasing glutamate 
addition with mid-sized, synchronized responses with lower AUC than cultures with 
severely depleted glial cells. Mildly depleted cultures behaved similarly to glia rich 
cultures. The difference between their AUC was not statistically significant. Studying 
how the brain behaves in altered systems, such as in glia depleted micro-environments 
adds to a body of work that explores cell loss in the brain and develop more targeted 
protective strategies. 
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6.2 Future Work 
It is anticipated, this combined experimental/analytical approach will also have 
utility in understanding additional brain diseases such as glioma and neurodegeneration 
linked to deregulated homeostatic calcium. To further the investigation of how neuronal 
calcium information processing is modulated by submaximal glutamate we must also 
investigate single neuronal responses over time for the different paradigms shown in these 
studies. Studying individual calcium dynamics could elucidate important aspects of 
spatiotemporal, synchronized, asynchrony and/or concentration dependent responses when 
correlated to the averaged calcium dynamics which were investigated throughout the body 
of this work.  
Before a biomaterial can be used for applications in the brain, it is important that 
an extensive study is done to elucidate all the possible effects this material can have on the 
brain. Calcium signalling in the brain can affect many neurological process and if 
dysregulated, may have harmful effects. As a result, future studies should be done to further 
understand how this material affect the calcium information processing of neural cells. A 
protocol for this method can be found in Appendix A8.  UV spectroscopy will be used to 
confirm that the CuHARS are successfully coated with the ionophore. After 
functionalization of CuHARS with ionomycin, the UV absorbance of the supernatant will 
be used to calculate the concentration using Beer’s law.  
Beer’s Law:𝐴 = ∈ 𝑏𝑐 
Where A = Absorbance 
 𝜖 = molar absorptivity/ Extinction co-efficient:𝜖278 = 18,200 
b= path length of the sample (path length of cuvette is 1cm) 
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C= concentration of compound (mol L-1) 
After each wash, the absorbance of the supernatant will be measures. If the absorbance 
decreases, we can infer that there is little or no A23187 on the CuHARS. After this is done, 
the materials can be used to stimulate neuronal cultures in calcium imaging experiments 
and this would confirm the presence of an ionophore on the material and not in the 
supernatant. 
Calcium Imaging can also be used to confirm that the CuHARS are coated with 
A23187. If the material is successfully coated with the ionophore, it can be used to 
stimulate a calcium fluorescent response in cells. Figure 6-1 is a flow chart illustrating the 
steps needed to successfully functionalize and confirm ionophore coated CuHARS. Blue 
lines have been completed and red lines will be done in future work. 
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Figure 6-1: Schematic illustrating the steps needed to successfully functionalize and 
confirm ionophore coated CuHARS. Blue lines have been completed and red lines will be 
done in future work. 
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APPENDIX A  
 
 
CELL CULTURE AND MEDIA  
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A1 Rat Primary Cervical Disarticulation: IACUC Approved 
Pre-treat plates with poly-lysine (PLL) using the following protocol: 
25 mg Poly-L-lysine (P-1274), Sigma 
1. Prepare 0.01% w/v coating buffer by dissolving 1.4mg PLL into 14 ml distilled 
water. 
2. Sterile filter this solution using a corning syringe filter (µm)  
3. Add 300µl of PLL to each well 
4. Let it stand for at least one hour in the tissue culture hood  
5. If this needs to be stored for more than 24 hours, add 1ml MEM culture media 
without antibiotics or serum into each well and store plate in 4°C. The coated 
plate could be stored safely for one week in this way (97). 
If more than seven pups will be sacrificed during the harvest, split the amount into groups 
of seven. Use a fresh 50 ml tube with 15 ml media and 750µl penicillin-streptomycin 
(PS) to collect tissue. 
Materials needed for dissection: 
1. Large petri dish 
2. Diapers 
3. Empty yellow-tip containers 
4. Plastic bag 
5. Cervical Scissors 
6. Micro-scissors 
7. Curve tip scissors 
8. Small tip forceps 
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9. Large forceps 
10. Small spatula 
11. Full wash bottle with 70% Isopropyl alcohol 
12. 50ml centrifuge tubes with 40ml basal media eagle (BME) 
13. 50ml centrifuge tube with 10ml BME and 0.05% PS (one for every 7 pups) 
14. Box of gloves 
15. 50ml centrifuge tube holder 
16. Beaker of ice 
Set-up for dissection: 
1. Soak the dissection instruments with 70% isopropyl alcohol in a container. 
2. Place the “pinkies” (pups) in the yellow container and set on one end of the 
dissection table. 
3. Place three diapers on the dissection table. 
4. Place one large petri dish under the microscope and pour ~10ml BME and PS into 
it. 
5. Place another petri dish about seven inches away from the dish under the 
microscope to be used for waste. 
6. Place and keep the plastic bag near the diapers. 
7.  Place the 50ml centrifuge tube holder on the dissection table next to the alcohol. 
8. Place the wash bottle next to the utensils. 
9. Keep the basal media, gloves, and other supplies on the cart. 
10. Place over-head lighting and stereo scope in position above the centered dish. 
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Dissection Protocol: 
1. Put on a pair of gloves. 
2. Remove one pup from the box by pinching the skin above the spine near the 
lower back and set the pinkie on a diaper. 
3. Spray pup with alcohol and pick up again using the pinch method. 
4. Quickly set cervical scissors behind ear being cautious of paws and make one 
very quick and decisive cut. (Dip scissors in alcohol and place it on a clean 
diaper) 
5. Blot the head at point of disarticulation on diaper and discard the body in the 
plastic bag. 
6. Using the micro-scissors, cut the skin in an upward motion then dip scissors in 
alcohol (This should expose the skull). 
7. Cut the skull using the same upward motion (this should expose the brain) 
8. Using large forceps, curl back both sides of the skull to better expose the brain 
then use a spatula to scoop out the brain into the basal media in the petri dish. 
9. Remove the cerebellum at the demarcation line and place it in the waste dish. 
10. Keep brain in place with large forceps and remove meninges and blood vessels 
with small forceps. Place the waste into the waste dish. 
11. Once all blood vessels and meninges are removed, place tissue into 50 ml tube. 
12. Repeat steps 2-11 until all pups are sacrificed. 
13. Discard of all waste into freezer room and clean all utensils. 
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Materials needed for tissue culture: 
1. Pre-treated plates with Poly-L-lysine 
2. Bucket of ice 
3. Neuronal Culture Media 
4. Trypsin EDTA  
Cell Harvest Protocol: 
1. Aspirate harvested brain tissue with a 10ml pipette into a 15 ml tube. 
2. Add 4ml of complete NCM and 1ml trypsin brain tissue then triturate about 15 
times. 
3. Let the brain tissue settle by placing it into a large beaker of ice for 5 minutes. 
4. The supernatant with contain the neuronal cells. Remove the supernatant and 
place it into another sterilized 15 ml centrifuge tube and place on ice. 
5. Repeat steps 2-4 two more time. 
6. Centrifuge and follow protocol to count and plate cells at a density of ~100,00 
cells per well. 
A2 Fluo3/AM Loading: 
Materials needed for 2ml imaging solution: 
1. 2µl Pluronic acid 
2. 4µl Fluo 3/AM 
3. 2ml Locke’s Solution (pre-warmed in incubator for at least 15 minutes) 
Protocol: 
1. Turn off the light of the cell culture hood 
2. Warm all components to room temperature prior to experiment. 
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3. Add 2ml of pre-warmed Locke’s solution to a 15 ml centrifuge tube 
4. Add 2µl pluronic acid to the tube then mix (vortex until soapsuds are observed) 
5. Add 4µl Fluo3/AM (2mg/ml in DMSO) and cap the tube. 
6. Mix the contents of the tube by gently inverting it two or three times. 
7. Remove all media from one well then add ~500µl of loading solution to the 
emptied well. 
8. Repeat step seven for all the wells to be imaged. 
9. Place the cell into the incubator and allow the dye to enter the cells for 45 minutes 
to an hour. 
10. Remove the loading solution and allow the cells to recover in 475µl of Locke’s 
solution for 30 minutes then the cells are ready for imaging. 
A3. MTT Assay Protocol 
1. Dissolve MTT crystals into 10X PBS to get a final concentration of 5mg/ml. 
2. Occasionally there may be some particulate material that will not dissolve; this 
can be removed by filtration or centrifugation.  
3. For adherent cells, remove the media from the well and replace it with 100µl of 
MTT solution. 
4. Incubate the cells at 37°C for 4 hours in a humidified chamber. 
5. Add 100µl of 91% isopropanol to each well and mix thoroughly using a pipette. 
6. Allow the plate to rest for ten minutes before measuring absorbance. 
7. Use the Thermo-Scientific Multiskan spectrum plate reader to read absorbance at 
570nm. 
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A4. Primary Neuronal Culture Media 
Material Needed: 
1. 25ml Fetal Bovine Serum (FBS) 
2. 25ml Horse Serum (HS) 
3.  98ml Ham’s F-12 K (Without glutamine) 
4.   98.25ml Basal Media Eagle 
5. 1.25ml PS 
6. 1.25ml Glucose solution in sterile distilled water (120mg/ml) 
7. 1.25 ml Glutamine in sterile distilled water (20mg/ml) 
8. Sterile Filtration Unit 
Protocol: 
1. Under the cell culture hood, transfer BME into filtration unit. 
2. Add thawed FBS and HS to filtration unit 
3. Add glucose solution, glutamine solution, PS and Ham’s F-12 K. 
4. Put the lid on the filtration unit, connect the hose then start vacuum 
5. Draw all liquid through then turn off the vacuum. 
6. Carefully remove the upper portion of the filtration unit under the hood then place 
the sterile cap on the bottle. 
7. Label the bottle with the name of the media, date, and your initials. 
A5. Primary Astrocyte Media 
Materials Needed: 
1. 12.5ml FBS 
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2. 12.5ml HS 
3. 1.25ml PS 
4. 223.75ml Ham’s F-12K media with L-glutamine 
5. Sterile Filtration Unit 
Protocol: 
1. Add 100ml Ham’s F-12K to vacuum filtration unit 
2. Add FBS, HS and PS 
3. Add 123.75ml of Ham’s F-12K 
4. Put the lid on the filtration unit, connect the hose, then start vacuum 
5. Draw all liquid through then turn off the vacuum. 
6. Carefully remove the upper portion of the filtration unit under the hood then place 
the sterile cap on the bottle. 
7. Label the bottle with the name of the media, date, and your initials. 
A5. Primary Microglia Media 
Materials Needed: 
1. 25ml FBS 
2. 2.5ml PS 
3. 222.5ml Dulbecco’s Modified Eagle’s Medium (DMEM) 
Protocol: 
1. Add 100ml Ham’s F-12K to vacuum filtration unit 
2. Add FBS and PS 
3. Add 122.5ml DMEM 
4. Put the lid on the filtration unit, connect the hose, then start vacuum 
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5. Draw all liquid through then turn off the vacuum. 
6. Carefully remove the upper portion of the filtration unit under the hood then place 
the sterile cap on the bottle. 
7. Label the bottle with the name of the media, date, and your initials. 
A6. Locke’s Solution 
Materials Needed: 
1. 2250 mg Sodium Chloride (NaCl) 
2. 104.4mg Potassium Chloride (KCl) 
3. 75.6mg Sodium Bicarbonate (NaHCO3) 
4. 84.5mg Calcium Chloride (CaCl2.2H2O) 
5. 252.3 mg Glucose (C6H12O6) 
6. 1.25ml of 1M Stock Solution (Ph 7.4) 
7. 248.75 distilled water (H2O) 
Protocol 
1. Dissolve all solid components into 100ml purified water. 
2. Add 100ml water to filtration unit 
3. Add solution made in step 1 to filtration unit 
4. Add Hepes solution 
5. Add remaining water 
6. Put the lid on the filtration unit, connect the hose, then start vacuum 
7. Draw all liquid through then turn off the vacuum. 
8. Carefully remove the upper portion of the filtration unit under the hood then place 
the sterile cap on the bottle. 
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9. Label the bottle with the name of the media, date, and your initials. 
A7. Immunohistochemistry 
DAPI Staining  
4',6-diamidino-2-phenylindole (DAPI):   
The blue fluorescent nucleic acid stain that preferentially binds to adenosine-thymine 
(AT) rich regions in double stranded DNA (dsDNA). When DAPI is bound to the dsDNA 
a ~20-fold fluorescence increase is observed (98).  The excitation maximum for bound 
DAPI is ~358nm and the emission maximum is 461nm. It is possible to excite the dye 
with a xenon or mercury-arc lamp or with a UV laser. DAPI can also be used in flow 
cytometry systems utilizing UV excitation sources (99). The protocol used to stain the 
cells is as followed: 
1. Equilibrate the sample briefly with phosphate-buffered saline (PBS). 
2. Dilute the DAPI stock solution to 300 nM in PBS. Add 300 µL of this dilute 
DAPI staining solution to the well, making certain that the cells are completely 
covered. 
3. Incubate for 1–5 minutes. 
4. Rinse the sample several times in PBS.  
5. View the sample using a fluorescence microscope with appropriate filters. 
A8.   Biocompatibility testing using Calcium Imaging 
1. Once the cells are harvested from the cortical region of the rat pup brains and 
resuspended in fresh astrocyte media, count the cells using a hemocytometer.  
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2. Plate the cells in 48 multi-well plates (cell culture treated, CellStar) at an optimal 
density (for calcium imaging) of 20,000 cells per well. Plate enough cells for 
experimentation for eighteen days. 
3. Add the material upon plating or 24 hours after the cells are plated 
4. Place the cell in an incubator to be maintained in 37 degrees Celsius (◦C), five 
percent carbon dioxide, and 100% humidity incubation.  
5. At four days in vitro, remove one plate and perform calcium imaging as described 
in chapter 3. 
6.  Repeat step five every four to five days while continuously adding media to ensure 
that the media in the well does not dry up. 
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APPENDIX B 
 
MAT LAB CODE  
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The data retrieved from the InCyt Im software will be in the following format. 
 
B1.  Area Under the Curve 
Instructions: 
1. Ensure that you set the path in Matlab. 
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The red arrow above shows how to change the folder in which Matlab is working. 
2. Select the folder that contains the code. The code will allow for the file path of 
the data to be defined whether the data is in the same folder as the code. 
3. Open the .m file and find the following block of code. 
4. Replace the dat.txt portion with the datafile’s name and extension (usually .txt). (In the 
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above example, I have the data and code in the same path. Thus, I didn’t need to specify a 
path like ~\Documents\Matlab\data.txt.) In the above picture, look at line 36. The %f is 
needed for each column of data. So, the code above assumes that there are six columns of 
numbers of floating type. It corresponds to the data shown in the picture. You of You will 
not always have six columns of data; therefore, you will need to add or delete some of the 
%fs on the code: 
 
Also, look at line 37 The number ‘6’ will be changed to the number of columns of data 
you have. 3) Save the modified code. Run it. It will ask you to specify the lower and 
upper bounds of integration. 
 
 
 
B2. Calcium Imaging Data 
This code is to gather header information 
 
function HDR = Calcium HDR(Filename) 
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%% Import data from text file. 
% Script for importing data from the following text file: 
% 
%    F:\R1C2_250glu_500g_750g.DAT 
% 
% To extend the code to different selected data or a different 
text file, 
% generate a function instead of a script. 
  
% Auto-generated by MATLAB on 2018/06/01 14:38:51 
  
%% Initialize variables. 
filename = Filename; 
delimiter = '\t'; 
  
%% Format for each line of text: 
%   column1: text (%s) 
%   column2: text (%s) 
%   column3: text (%s) 
%   column4: text (%s) 
%   column5: text (%s) 
%   column6: text (%s) 
% For more information, see the TEXTSCAN documentation. 
format Spec = '%s%s%s%s%s%s%[^\n\r]'; 
  
%% Open the text file. 
fileID = fopen(filename,'r'); 
  
%% Read columns of data according to the format. 
% This call is based on the structure of the file used to 
generate this 
% code. If an error occurs for a different file, try regenerating 
the code 
% from the Import Tool. 
dataArray = textscan(fileID, formatSpec, 'Delimiter', delimiter, 
'TextType', 'string',  'ReturnOnError', false); 
  
%% Close the text file. 
fclose(fileID); 
  
%% Post processing for unimportable data. 
% No unimportable data rules were applied during the import, so 
no post 
% processing code is included. To generate code which works for 
% unimportable data, select unimportable cells in a file and 
regenerate the 
% script. 
  
%% Create output variable 
RawData = [dataArray{1:end-1}]; % Get raw data 
  
% Data to find 
ToFind = 
{'Experiment_Code','Ion','Wavelength_Used','Other_Wavelength','Exposure
_Time',... 
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'Minimum_Fluorescence','Maximum_Fluorescence','Image_Width',... 
    'Image_Height','Number_of_Time_Points','Number_of_Objects'}; 
  
for idx = 1:size(ToFind,2) 
     
    ToFindCol = false(1,size(RawData,2)); % Pre-allocate for 
speed 
  
    ToFindRow = contains(RawData(:,1),ToFind{idx}); % Find rows 
for header info 
    ToFindCol(2:end) = arrayfun(@(Col) 
~isempty(RawData{ToFindRow,Col}),2:size(RawData,2)); % Find the column 
of header info 
  
    if idx <= 2 
        HDR.(ToFind{idx}) = RawData{ToFindRow,ToFindCol}; % Store 
the header info     
    else 
        HDR.(ToFind{idx}) = 
str2double(RawData{ToFindRow,ToFindCol}); % Store the header info 
    end 
  
end 
  
%% Find Object Areas 
  
Object_AreasRow = find(contains(RawData(:,1),'object')); % Find 
rows for header info 
Object_AreasCol = nan(size(Object_AreasRow,1),1); % Pre-allocate 
for speed 
HDR.Object_Areas = nan(1,size(Object_AreasRow,1)); % Pre-allocate 
for speed 
  
  
for idx = 1:size(Object_AreasRow,1) 
    Object_AreasCol(idx) = find(arrayfun(@(Col) 
~isempty(RawData{Object_AreasRow(idx),Col}),3:size(RawData,2)))+2; % 
Find the column of header info 
     
    HDR.Object_Areas(idx) = 
str2double(RawData{Object_AreasRow(idx),Object_AreasCol(idx)}); % Save 
data to HDR variable 
end 
  
%% Find # of Events and Event Times 
  
Number_of_EventsRow = find(contains(RawData(:,1),'Event_Times')); 
% Find rows for header info 
Number_of_EventsCol = false(1,size(RawData,2)); % Pre-allocate 
for speed 
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Number_of_EventsCol(1,2:end) = arrayfun(@(Col) 
~isempty(RawData{Number_of_EventsRow,Col}),2:size(RawData,2)); % Find 
the column of header info 
  
HDR.Number_of_Events = 
str2double(RawData{Number_of_EventsRow,Number_of_EventsCol}); % Save 
data to HDR variable 
  
HDR.Events = nan(1,HDR.Number_of_Events); % Pre-allocate for 
speed 
EventsCol = nan(1,HDR.Number_of_Events); % Pre-allocate for speed 
  
for idx = 1:HDR.Number_of_Events 
    EventsCol(idx) = find(arrayfun(@(Col) 
~isempty(RawData{Number_of_EventsRow+idx,Col}),1:size(RawData,2))); % 
Find the column of header info 
     
    HDR.Events(idx) = 
str2double(RawData{Number_of_EventsRow+idx,EventsCol(idx)}); % Save 
data to HDR variable 
end 
  
HDR = orderfields(HDR); %Alphabetize the header information 
  
end 
 
Code for the other function used to gather the data 
function[Time, ObjectData] = CalciumData(Filename,HDR) 
  
%% Import data from text file. 
% Script for importing data from the following text file: 
% 
%    F:\R1C2_250glu_500g_750g.DAT 
% 
% To extend the code to different selected data or a different 
text file, 
% generate a function instead of a script. 
  
% Auto-generated by MATLAB on 2018/06/01 14:38:51 
  
%% Initialize variables. 
filename = Filename; 
delimiter = '\t'; 
  
%% Format for each line of text: 
%   column1: text (%s) 
%   column2: text (%s) 
%   column3: text (%s) 
%   column4: text (%s) 
%   column5: text (%s) 
%   column6: text (%s) 
122 
%   column7: text (%s) 
% For more information, see the TEXTSCAN documentation. 
formatSpec = '%s%s%s%s%s%s%s%[^\n\r]'; 
  
%% Open the text file. 
fileID = fopen(filename,'r'); 
  
%% Read columns of data according to the format. 
% This call is based on the structure of the file used to 
generate this 
% code. If an error occurs for a different file, try regenerating 
the code 
% from the Import Tool. 
dataArray = textscan(fileID, formatSpec, 'Delimiter', delimiter, 
'TextType', 'string',  'ReturnOnError', false); 
  
%% Close the text file. 
fclose(fileID); 
  
%% Post processing for unimportable data. 
% No unimportable data rules were applied during the import, so 
no post 
% processing code is included. To generate code which works for 
% unimportable data, select unimportable cells in a file and 
regenerate the 
% script. 
  
%% Create output variable 
RawData = [dataArray{1:end-1}]; % Get raw data 
  
% Data to find 
  
DataStartRow = 
find(contains(RawData(:,1),'DATA_AFTER_THIS_LINE'))+2; % Find the row 
for the first data point 
DataStopRow = DataStartRow-1 + HDR.Number_of_Time_Points; % Find 
the row for the last data point 
  
TimeCol = find(contains(RawData(DataStartRow-1,:),'Time')); % 
Find rows for header info 
  
TimeDouble = arrayfun(@(Rows) 
str2double(RawData{Rows,TimeCol}),DataStartRow:DataStopRow)'; % Store 
time values 
  
% TimeTypeRaw = RawData{DataStartRow-1,TimeCol}; 
% TimeTypeStr = cell2mat(regexp(TimeTypeRaw,'[a-zA-
Z]*(?=])','match')); 
% TimeType = str2func(TimeTypeStr); 
% Time = TimeType(TimeDouble); % Change time from double to 
duration 
  
Time = TimeDouble; % Keep time as double if an error is thrown 
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ObjectData = 
nan(HDR.Number_of_Time_Points,HDR.Number_of_Objects); % Pre-allocate 
for speed 
  
for Col = 1:HDR.Number_of_Objects 
    ObjectData(:,Col) = arrayfun(@(Rows) 
str2double(RawData{Rows,Col+TimeCol}),DataStartRow:DataStopRow)'; % 
Store object values 
end 
  
subplot(2,1,1) 
plot(Time,ObjectData) %Plot ObjectData vs. Time 
RangeOfGraph = get(gca, 'ylim'); %Determine max and min for y-
axis 
xlabel('Time (seconds)') %X-axis label = Time(seconds) 
ylabel('R.O.I. Fluorescence Values') %Y-axis label = ROI 
Fluorescence values 
grid on %Turn on grid for plot 
title('Fluorescence vs. Time') %Give plot a title 
hold on  
  
for Index2 = 1:HDR.Number_of_Objects %Produce input for legend 
(indexes appropriately with # of ROIS present) 
    names{Index2} = ['Object ' num2str(Index2)]; %Add Object 
1,2,3...N to legend of plot 
end 
legend(names,'Location','NorthEastOutside') %Determine legend 
location relative to plot 
  
for Index3 = 1:size(HDR.Events,2) %Add marker (vertical line) 
wherever an event occurs 
   line([HDR.Events(Index3) HDR.Events(Index3)] ,RangeOfGraph) 
%create vertical line at specific time point 
end 
  
Average_Waveform = NaN(size(ObjectData,1),1); %Preallocate for 
speed 
for Index4 = 1:size(ObjectData,1)  
    Summation_Row = 0; %Preallocate Summation_Row 
    for Index5 = 1:size(ObjectData,2) 
    Summation_Row = Summation_Row+ObjectData(Index4,Index5); %Sum 
Row 
    end 
    Average_Row = Summation_Row/size(ObjectData,2); %Average the 
row 
    Average_Waveform(Index4,1) = Average_Row; %Create 
average_waveform matrix which is average_row instanced 
size(ObjectData,1) times 
end 
hold off 
  
subplot(2,1,2) 
plot(Time,Average_Waveform,'Linewidth',2) %plot average_waveform 
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DomainOfGraph1 = get(gca, 'xlim'); %Determine max and min on x-
axis 
RangeOfGraph1 = get(gca, 'ylim'); %Determine max and min on y-
axis 
xlabel('Time (seconds)') %X-axis label = Time(seconds) 
ylabel('R.O.I. Fluorescence Values') %Y-axis label = ROI 
Fluorescence values 
grid on %Turn on grid for plot 
title('Fluorescence vs. Time') %Give plot a title 
legend('Average', 'Location', 'NorthEastOutside')  %Determine 
legend location relative to plot 
hold on 
  
for Index6 = 1:size(HDR.Events,2) %Add marker (vertical line) to 
graph whenever event occurs 
   line([HDR.Events(Index6) HDR.Events(Index6)] ,RangeOfGraph1) 
%create verticl line at specific time point 
end 
  
hold off 
% line(DomainOfGraph1,[1.2*Average_Waveform(1) 
1.2*Average_Waveform(1)]) %Plot threshold line for 1.2*Baseline of 
average_waveform 
% hold off %End holding so if this function is ran again in the 
same sitting, it will not keep the waveforms on the plot 
  
% names{HDR.Number_of_Objects+1} = 'Average'; %After Object N, 
add average_waveform to plot legend 
  
end 
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C.2   Dynamic Models of Neuron: Astrocyte Interaction 
C2.1  The Neuron Model   
𝐶
𝑑𝑣𝑗(𝑡)
𝑑𝑡
= −?̅?𝐶𝑎𝑚∞ (𝑣𝑗(𝑡)) (𝑣𝑗(𝑡) − 𝑣𝐶𝑎) −  ?̅?𝐾𝑤𝑗(𝑡)(𝑣𝑗(𝑡) − 𝑣𝑘)
−  ?̅?𝐿 (𝑣𝑗(𝑡) −  𝑣𝐿 ) + 𝑖𝑗(𝑡) 
          Eqn. C-1 
 
𝑑𝑤𝑗(𝑡)
𝑑𝑡
=  ∅ [
𝑤∞( 𝑣𝑗(𝑡) − 𝑤𝑗(𝑡)]
𝜏𝑤 (𝑣𝑗(𝑡))
) 
          Eqn. C-2 
𝑖𝑗(𝑡) =  𝑖𝑗
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡(𝑡) +  𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) +  𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡)           Eqn. C-3 
𝑑𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡)
𝑑𝑡
= 𝜀𝑗 (𝑣
∗ −  𝑣𝑗(𝑡) −  𝛼𝑗𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡)) 
          Eqn. C-4 
  A modified version of the Morris-Lecar equation is used as the basic model for each 
neuron (73).    
where wj is an auxiliary variable and is the fraction of open K+ channels. The channel 
conductances ?̅?Ca, ?̅?K, and ?̅?L for the Ca2+, K+ and leak currents are constants. The 
functions m∞ v j(t), 𝑤∞( 𝑣𝑗(𝑡)and 𝜏𝑤 (𝑣𝑗(𝑡)control the dynamics of the ion channels and 
are defined by the following equations: 
𝑚∞ (𝑣𝑗(𝑡)) = 𝑜. 5 [1 + tanh (
𝑣𝑗(𝑡) − 𝑣1
𝑣2
)] 
                     Eqn.  C-4 
𝑤∞ (𝑣𝑗(𝑡)) = 𝑜. 5 [1 + tanh (
𝑣𝑗(𝑡) − 𝑣3
𝑣4
)] 
                      Eqn. C-5 
𝜏𝒘 (𝑣𝑗(𝑡)) =  
1
cosh (
(𝑣𝑗(𝑡)) − 𝑣3
2𝑣4
)
 
                      Eqn. C-6 
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𝑖𝑗(𝑡)is the applied current to the jth neuron. This contains a constant background current 
𝑖𝑗
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡(𝑡), a slow, fluctuating current 𝑖𝑗
𝑠𝑙𝑜𝑤(71), and a noisy current ( 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) with 
amplitude Dn and correlation Ʈn ) which models the unavoidable noise found within 
physiological systems. 𝜀𝑗 and 𝛼𝑗 control the bursting behavior of the jth neuron. Because 
of the constant slow currents 𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡), the neuron displays dynamic behavior.  
The following equations are the compact form of Eqns. 4-1 to 4-8. 
𝑑𝑣𝑗
𝑑𝑡
= 𝐹(𝑣𝑗 , 𝑤𝑗, 𝑖𝑗) 
                                                   Eqn. C-7 
𝑑𝑤𝑗
𝑑𝑡
= 𝐺(𝑣𝑗 , 𝑤𝑗) 
                                                 Eqn. C-8                  
  
Where, 
𝐹(𝑣𝑗 , 𝑤𝑗, 𝑖𝑗) =  −?̅?𝐶𝑎𝑚∞ (𝑣𝑗(𝑡)) (𝑣𝑗(𝑡) − 𝑣𝐶𝑎)
− ?̅?𝑘𝑤𝑗(𝑡)(𝑣𝑗(𝑡) − 𝑣𝐾) − ?̅?𝐿(𝑣𝑗(𝑡) − 𝑣𝐿) +  𝑖𝑗(𝑡) 
 
   Eqn. C-9 
𝐺(𝑣𝑗 , 𝑤𝑗) = ∅(𝑤∞ (
𝑣𝑗(𝑡) − 𝑤𝑗(𝑡)
𝜏𝑤 (𝑣𝑗(𝑡))
) 
 
Eqn. C-10 
A mathematical model of a neuronal network consisting of two neurons (M-L) connecting 
via gap junctions has been developed and is described in the following equations (74): 
𝑑𝑣1
𝑑𝑡
= 𝑓(𝑣1, 𝑤1, 𝑖1) + 𝑔𝑠𝑒(𝑣2 − 𝑣1) 
 Eqn. C-11 
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𝑑𝑣2
𝑑𝑡
= 𝑓(𝑣2, 𝑤2, 𝑖2)  + 𝑔𝑠𝑖(𝑣1 − 𝑣2) 
Eqn. C-12 
𝑑𝑤1
𝑑𝑡
= 𝐺(𝑣1, 𝑤1) 
       Eqn. C-13 
𝑑𝑤2
𝑑𝑡
= 𝐺(𝑣2, 𝑤2) 
                   Eqn. C-14 
The variables 𝑔𝑠𝑒 and 𝑔𝑠𝑖 are the maximal conductances for excitatory or inhibitory 
synaptic connections (gap junctions). These numbers are always positive and can be 
referred to as coupling constants. 𝑔𝑠𝑒 is used to change the excitation level and an increase 
in 𝑔𝑠𝑒 causes an enhancement of the coupling strength between neurons and can therefore 
also affects neural synchrony. 
C2.2   The Astrocyte Model 
It has been proven that astrocytes play an active role in synaptic activity. These cells have 
numerous receptors but do not have adequate voltage- gated sodium channels to exhibit 
electrical excitability. Excitation of astrocytes takes place via calcium influx. Increased 
intracellular calcium concentration in astrocytes causes the release of glutamate, ATP and 
other neuroactive chemicals that are involved in controlling the synaptic activity of nearby 
neurons(75). Figure C-1 shows the main mechanism for neuron-astrocyte interactions 
which will be modelled mathematically.  
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Figure C-1: A schematic of the main pathways for neuron–astrocyte interactions: (1) 
Release of glutamate from the presynaptic neuron activates astrocytic receptors and (2) 
induces an increase in intracellular Ca2+ levels. (3) The release of glutamate from astrocyte 
activates presynaptic receptors and regulates neurotransmitter release, while (4) activation 
of postsynaptic receptors directly depolarizes neurons. (5) Stimulation of astrocyte elicits 
also the release of ATP which, in turn, inhibits nearby neurons(76) 
 
 
A dynamic model introduced by Postnov et al. (77, 78) is used to describe the intracellular 
calcium waves produced by astrocytes. This model is shown in the following equations: 
𝜏𝑐
𝑑𝑐
𝑑𝑡
=  −𝑐 − 𝑐4𝑓(𝑐, 𝑐𝑒) + (𝑟 + 𝛽𝑆𝑚) 
 Eqn. C-15 
𝜀𝑐𝜏𝑐
𝑑𝑐𝑒
𝑑𝑡
=  𝑓(𝑐, 𝑐𝑒) 
Eqn. C-16 
𝑓(𝑐, 𝑐𝑒) =  𝑐1
𝑐2
1 + 𝑐2
− (
𝑐𝑒
2
1 + 𝑐𝑒2
) (
𝑐4
𝑐2
4 + 𝑐4
) − 𝑐3𝑐𝑒 
Eqn. C-17 
𝜏𝑆𝑚
𝑑𝑆𝑚
𝑑𝑡
= (1 + tan h [𝑆𝑆𝑚(𝑧 − ℎ𝑆𝑚)]) ∗ (1 − 𝑆𝑚) −
𝑆𝑚
𝑑𝑆𝑚
 
Eqn. C-18 
𝜏𝐺𝑚
𝑑𝐺𝑚
𝑑𝑡
= (1 + tan h [𝑆𝐺𝑚(𝑧 − ℎ𝐺𝑚)]) ∗ (1 − 𝐺𝑚) −
𝐺𝑚
𝑑𝐺𝑚
 
Eqn. C-19 
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The variables, 𝑐 and 𝑐𝑒 denotes the astrocyte cytoplasmic calcium concentration and the 
calcium concentration within the endoplasmic reticulum respectively. The parameters 𝜀𝑐 
and 𝜏𝑐 are used to define the characteristic time for calcium oscillation. The influx of 
calcium is modulated by the production of secondary messenger (𝑆𝑚) IP3. The movement 
of calcium between the ER and the cytoplasm is defined by the non-linear function 𝑓(𝑐, 𝑐𝑒). 
During simulations, the control parameters 𝑟, 𝛽, 𝜏𝑐, 𝜏𝑆𝑚 ,𝜏𝐺𝑚,𝑆𝑆𝑚 , 𝑆𝐺𝑚,ℎ𝑆𝑚 , ℎ𝐺𝑚 , 𝑑𝑆𝑚,𝑑𝐺𝑚are 
set to the values listed in Table C-1. These values are taken from Amiri et al. (74).  
 
Table C-1: Parameter values used in the simulations (74) 
          
𝑐1 0.13 𝑐2 0.9 𝑐3 0.004 𝑐4 1
𝜀𝑐
 
𝑟 0.02 
𝛽 1 𝜏𝑆𝑚  10 ℎ𝑆𝑚  0.015  𝑑𝑆𝑚  0.071 𝜏𝑐 2 
𝑆𝑆𝑚  100    a 2 𝜀𝑐 0.01 𝐷𝑛 10
-5 𝜏𝑛 5 
?̅?𝐶𝑎 1 ?̅?𝑘 2 ?̅?𝐿 0.5 ∅ 1.107 𝑣2 0.15 
𝑣4 0.145 𝑣
+ -0.217 𝜎𝑠 0.02 𝛽𝑠 0.05 ∅𝑠 0.2 
𝑣𝐶𝑎 1 𝑣𝑘 -0.7 𝑣𝐿 -0.5 𝑣1 -0.01 𝑣3 0.1 
𝛼𝑖 0.0001 𝑔𝑠𝑖 0.0051 𝐶 1   𝑖𝑗
𝑐𝑜𝑛𝑠𝑡 0.02 𝜀𝑗 0.002 
 
C2.3    Modeling Astrocyte Interactions with Two Coupled Neurons 
The two Morris-Lecar neuron model is extended to add the modulating activity of 
astrocytes on signal strength.  For the sake of mathematical simplicity, the two neurons are 
connected via gap junctions. Neuron-astrocyte interactions are modeled by a chemical 
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synapse to model the tripartite synapse. The concentration of neurotransmitter in the 
synaptic cleft is modeled by the following equation: 
[𝑇]𝑗 =
1
1 + exp (−
𝑣𝑗(𝑡) − 𝜃𝑠
𝜎𝑠
)
, 𝑗 = 1.2 
Eqn. C-20 
where θs and σs are half-activation voltage and steepness of the sigmoid function, 
respectively. The input of an astrocyte (z) is concentration of the neurotransmitter ([T] j) 
released by activated neuron, and it triggers the IP3 production. This is defined by:  
𝑧 = 𝑎 ∑[𝑇]𝑗
2
𝑗=1
 
Eqn. C-21 
The variable a is greater than zero and is an amplifying parameter. The output of the 
astrocyte is as follows: 
𝑖𝑗
𝑎𝑠𝑡 = 𝜆𝑗 •  𝐺𝑚, 𝑗 = 1,2 Eqn. C-22 
Astrocyte interactions can either have excitatory or inhibitory effects on neurons. For this 
model, excitatory effects of astrocytes on neurons are indicated by positive signs and 
inhibitory effects, negative signs. To illustrate these interactions of astrocytes with 
neighboring neurons “+𝑖𝑎𝑠𝑡” and “-𝑖𝑎𝑠𝑡”  is added to Equation 4-3. The complete equations 
for the current of the neuron are as follows: 
𝑖1(𝑡) =  𝑖𝑗
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡(𝑡) + 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) +  𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡) + 𝑖𝑗
𝑎𝑠𝑡(𝑡) 
 
Eqn. C-23 
𝑖2(𝑡) =  𝑖𝑗
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡(𝑡) + 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) +  𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡) − 𝑖𝑗
𝑎𝑠𝑡(𝑡) Eqn. C-24 
𝑖𝑗
𝑎𝑠𝑡(𝑡) =  𝜆𝑗 • 𝐺𝑚 and 𝜆𝑗 > 0 
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The coupled Morris-Lecar model is also modified to include the astrocyte outputs as 
follows:  
𝑑𝑣1
𝑑𝑡
= 𝑓(𝑣1, 𝑤1, 𝑖1 − 𝑖1
𝑎𝑠𝑡(𝑡))
+ 𝑔𝑠𝑒(𝑣2 − 𝑣1) + 𝑖1
𝑎𝑠𝑡(𝑡) 
Eqn. C-25 
𝑑𝑣2
𝑑𝑡
= 𝑓(𝑣2, 𝑤2, 𝑖2 − 𝑖2
𝑎𝑠𝑡(𝑡))  +
                        𝑔𝑠𝑖(𝑣1 − 𝑣2)+ 𝑖2
𝑎𝑠𝑡(𝑡) 
Eqn. C-26 
 
 
 
C2.4    Computational Analysis of Neural Synchrony 
To mathematically analyze the effect of astrocytes on neural synchrony, one much 
first define the concept of synchronization. Two theorems have been provided by 
Labourian et al. and Wang et al. to describe neural synchrony(79). Amiri et al. went on to 
use these theorems to also describe neural desynchronization in the presence of astrocytes.  
The theorem simply states that if two neurons are strongly coupled, they can be 
synchronized regardless of the initial conditions and parameter values(74). The 
physiological situation in which astrocyte contribution to synaptic regulation is considered. 
Results of this simulation is shown in Figure C-1. The top panel shows the increase 
of coupling level, gse, and the middle panel demonstrates the membrane potential of the 
coupled neurons. In this simulation, it is assumed that the astrocyte begins to interact with 
the coupled neurons at t = 7000 s. It is shown here that the astrocyte modifies the synaptic 
currents by providing appropriate feedback actions. Consequently, runaway excitation is 
compensated, and normal asynchronous behavior is again resumed quickly. 
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Figure C-2:  The effect of varying coupling strength (gse) in two coupled neurons in which 
the interaction of astrocyte with the individual neurons is included for t > 7000 s.  
 
 
In this case, astrocyte provides balanced excitation and inhibition to coordinate synaptic 
interactions. The bottom panel shows the synchronization index. It is apparent that the 
concurrent firing of neurons is disturbed by feedback from astrocyte. 
C2.4    Neural Population Model 
The minimal, two M-L neuron mathematical model can be extended to a model 
consisting of 50 pyramidal neurons (PY) and 50 interneurons (IN) that are arranged in a 
rectangular grid with dimensions 0.1 X 0.1spartial units. The feed forward inhibition of 
pyramidal neurons by adjacent interneurons is considered within this model. The total 
synaptic current of the jth neuron from the other neurons within the population is given as 
follows (80): 
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𝑖𝑗
𝑠𝑦𝑠(𝑡) = 𝑔𝑠𝑒(𝑣𝑗(𝑡) −  𝑣𝑠𝑒) ∑ 𝑔𝑖(𝑡) + 𝑔𝑠𝑖(𝑣𝑗(𝑡)
𝑖;𝑒𝑥𝑐
− 𝑣𝑠𝑖) ∑ 𝑔𝑖
𝑖;𝑖𝑛ℎ
(𝑡) 
        Eqn. C-27 
𝑔𝑠𝑒 and 𝑔𝑠𝑖 are the conductances of the excitatory and inhibitory synapses, 𝑣𝑠𝑒  and 𝑣𝑠𝑖 are 
excitatory and inhibitory reversal potentials and the sum is taken with respect to the index 
𝑖 running over excitatory and inhibitory synapses. The current for individual neurons 
within the population is as follows: 
𝑖𝑗(𝑡) =  𝑖𝑗
𝑐𝑜𝑛𝑠𝑡 (𝑡) + 𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡) + 𝑖𝑗
𝑠𝑦𝑠(𝑡) + 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡)                                   Eqn. C-28 
The excitatory synapse conductance (𝑔𝑠𝑒) is used to control the level of excitation within 
the system. The local field potential of the neuronal population is measured as follows: 
𝑣𝑜(𝑡) = (
𝑅𝑒
4𝜋
) ∑ (
𝑖𝑣𝑗(𝑡)
𝑟𝑗
)
𝑗
 
                                                    Eqn. C-29 
𝑅𝑒 is the extracellular resistance and is assumed to be homogeneous. To normalize the 
output signal, 𝑣𝑜(𝑡), we use: 
𝑅𝑒 = 4𝜋 ∑ 𝑟𝑗. 𝑖𝑣𝑗(𝑡)
𝑗
 
                                                    Eqn. C-30 
∑ 𝑟𝑗 . 𝑖𝑣𝑗(𝑡)𝑗  is the sum f the ionic currents and 𝑟𝑗 is the distance between the jth and the 
electrode used to measure the currents. A low pass filter is then used to filter the output 
signal 𝑣0(𝑡)as follows: 
𝑑𝑣𝑗
𝑑𝑡
=  𝑣0 − 0.1𝑣𝑓(𝑡) 
                                                    Eqn. C-31 
As a result, when the neurons are synchronized, the output of the filter has a high amplitude 
and in an asynchronous population, the output is very noisy. 
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C2.5    Astrocyte model for the neural population 
The dynamic model developed based on the Li-Rinzel model(81). This model is 
illustrated by the following equations: 
𝑑[𝐼𝑃3]
𝑑𝑡
=
(𝐼𝑃3
∗ − 𝐼𝑃3)
𝜏𝐼𝑃3
+ 𝑟𝐼𝑃3[𝑇] 
                                                Eqn. C-32 
𝑑[𝐶𝑎2+]
𝑑𝑡
=  𝐽𝑐ℎ𝑎𝑛 − 𝐽𝑝𝑢𝑚𝑝 + 𝐽𝑙𝑒𝑎𝑘 
                                                Eqn. C-33 
𝑑𝑞
𝑑𝑡
= 𝛼𝑞(1 − 𝑞) − 𝛽𝑞𝑞 
                                                Eqn. C-34 
[𝐶𝑎2+]is the cytosolic calcium concentration, 𝑞 is the fraction of activated IP3 receptors 
and IP3
* is the equilibrium IP3 concentration. 𝐽𝑐ℎ𝑎𝑛, 𝐽𝑝𝑢𝑚𝑝 and 𝐽𝑙𝑒𝑎𝑘 are the calcium influx 
from the ER to the cytosol, the pump flux from the cytoplasm to ER, and the leakage flux 
from the ER to cytosol, respectively. These values are given in the following expressions: 
𝐽𝑐ℎ𝑎𝑛 = 𝑐1𝑣1𝑝∞
3 𝑛∞
3 𝑞3([𝐶𝑎2+]𝐸𝑅 − [𝐶𝑎
2+])                                              Eqn. C-35 
𝐽𝑙𝑒𝑎𝑘 = 𝑐1𝑣1([𝐶𝑎
2+]𝐸𝑅 − [𝐶𝑎
2+])                                             Eqn. C-36 
𝐽𝑝𝑢𝑚𝑝 =
𝑣3[𝐶𝑎
2+]2
[𝐶𝑎2+] + 𝑘3
2 
                                            Eqn. C-37 
                     𝑝∞ =
[𝐼𝑃3]
[𝐼𝑃3]+𝑑1
                                             Eqn. C-38 
𝑛∞ =
[𝐶𝑎2+]
[𝐶𝑎2+] + 𝑑5
 
                                            Eqn. C-39 
𝛼𝑞 = 𝑎2𝑑2
[𝐼𝑃3] + 𝑑1
[𝐼𝑃3] + 𝑑3
 
                                            Eqn. C-40 
𝛽𝑞 = 𝑎2[𝐶𝑎
2+]                                             Eqn. C-41 
[𝐶𝑎2+]𝐸𝑅 =
𝑐0 − [𝐶𝑎
2+]
𝑐1
=
 
                                            Eqn. C-42 
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[𝐶𝑎2+]𝐸𝑅 is the concentration of calcium within the endoplasmic reticulum (ER). 
C2.6    Astrocyte -Neuron interaction for the neural population 
The model for astrocyte- neuron interactions for the neural population is as follows: 
𝑑𝑓
𝑑𝑡
=
−𝑓
𝜏𝐶𝑎2+
+ (1 − 𝑓)𝐾∅([𝐶𝑎2+] − [𝐶𝑎2+]𝑡ℎ) 
                              Eqn. C-43 
Where ∅ is the Heaviside function and 𝐾 is the scaling factor. To model astrocyte coupling, 
the differential equation for IP3 concentration is modified by adding the intracellular 
coupling term JG. 
𝐽𝐺 = ∑ 𝑘𝑔𝑗([𝐼𝑃3]𝑗 − [𝐼𝑃3]𝑖)  
𝑗
 
                                                Eqn. C-44 
𝑘𝑔𝑗 denotes the coupling co-efficient for gap-junctional diffusion from the jth astrocyte. 
Astrocytes within a neural circuit have similar 𝑘𝑔𝑗. The output of the astrocyte is: 
𝑖𝑎𝑠𝑡 = 𝛾. 𝑓                                                  Eqn. C-45 
The full expression for the current of the jth pyramidal neuron is: 
𝑖𝑗
𝑃𝑌(𝑡) = 𝑖𝑗
𝑐𝑜𝑛𝑠𝑡(𝑡) + 𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡) + 𝑖𝑗
𝑠𝑦𝑠(𝑡) + 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) − 𝑖𝑗
𝑎𝑠𝑡(𝑡)                 Eqn. C-46 
The full expression for the current of the jth interneuron is: 
𝑖𝑗
𝐼𝑁(𝑡) = 𝑖𝑗
𝑐𝑜𝑛𝑠𝑡(𝑡) + 𝑖𝑗
𝑠𝑙𝑜𝑤(𝑡) + 𝑖𝑗
𝑠𝑦𝑠(𝑡) + 𝑖𝑗
𝑛𝑜𝑖𝑠𝑒(𝑡) + 𝑖𝑗
𝑎𝑠𝑡(𝑡)                 Eqn. C-47 
The values of the parameters used for the simulations are shown in Table 4-2. 
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Table C-2: Parameters used in the simulation of the extended neural population model(8) 
 
𝑣1 6s
-1 𝑘3 0.1 µM 𝑑3 0.94 µM 
𝐼𝑃3
∗ 0.16µM 𝑣2 0.11 s
-1 𝑑1 0.13 µM 
𝑐1 0.185 𝑣3 0.9 µM s
-1 𝑑2 1.05 µM 
𝑟𝐼𝑃3 7.2mMs
-1 ?̅?𝑘 2 ?̅?𝐿 0.5 
𝑐1 0.185 𝑣
∗ -0.22 𝜎𝑠 0.02 
?̅?𝐶𝑎 1 𝑣𝑘 -0.7 𝑣𝐿 -0.5 
𝑣4 0.145 𝜃𝑠 0.2 𝛼𝑠 0.1 
𝑣𝑎 1 ?̅?𝑠𝑖 0.1 [𝐶𝑎]𝑡ℎ 0.2 
 
Simulation results of the proposed model under different conditions are presented. All the 
simulations were implemented in Simulink (MATLAB). 
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Figure C-3: The effect of increasing astrocyte-neuron interactions in the neural population 
model. (a) and (e) show the profile of increasing coupling strength gse. (b)–(d) show the 
LFP recorded by the measurement electrode and (f)–(h) show the synchronization index 
for the different level of astrocyte-neuron interactions. (b) and (f) show the results of 
simulation for the neuronal population of Fig. 3(a) which is a neuronal network without 
astrocyte or equivalently γ10γ200. In this case, increasing gse leads to the neurons in the 
population get synchronized. (c) and (g) are for the extended neuronal networks in which 
astrocyte neuron interactions are also considered. For these simulations γ100.25 and 
γ200.2. In this case, due to the astrocyte neuron interaction, neuronal synchrony has been 
decreased compared to (b) and (f). In (d) and (h), the astrocyte-neuron interactions are 
again increased by setting γ100.7 and γ200.6 which leads to the asynchronous firing of the 
neurons. 
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